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Abbreviation 
CF 5(6)-Carboxyfluorescein 
CG Cetearyl glucoside  
DSPG 1,2-Distearyl-sh-glycero-3-phospho-rac-glycerol 
DSPS 1,2-Distearyl-sn-glycero-3-phosphoserine 
EM EMULSENSE®; Brassicyl isoleucinate esylate  
LPC20 Phospholipon® R LPC 20 (partially hydrolysed rapeseed Lecithin 
containing lysophosphatidylcholine 20%) 
NAT NAT® 8539 (Soybean phosphatidylcholine (SPC) dissolved in ethanol 
containing: 77% phosphatidylcholine) 
NMR Nuclear magnetic resonance 
PEG Polyethyleneglycol 
PG Polyglycerol 
PGMO Polyglycerol monooleate 
PL90G Phospholipon® 90G; PL90G (phosphatidylcholine > 95%) 
QA quaternary ammonium compound with isopropanol (15%) 
(Behentrimonium Chloride 85%; VARISOFT BT 85 PELLETS®) 
SO Sucrose oleate (SURFHOPE® SE COSME)  
TE polyglycerol-3 methylglucose distearate (TEGO CARE 450®) 
TP Terpene mixture (limonene: citral: cineole = 1: 4.5: 4.5, v/v) 
TW Tween 80
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Introduction 
Dermal drug delivery is of global interest in the pharmaceutical and cosmetic 
productions. Its advantages over other routes of administration (such as oral and 
intravenous routes) include 1) avoidance of the hepatic first pass effect, 2) 
decreased side effects of drugs and 3) improved patient compliance. Traditionally, 
conventional liposomes are chosen by the large majority of researches as the 
candidate of vesicle tool for enhancing the drug penetration. Even though the 
conventional liposomes could enhance dermal drug delivery to a certain degree, 
they however have some disadvantages per se, and can be subjected to further 
improvement. Recent studies have demonstrated the various vesicular formulations 
(such as deformable liposomes, niosomes) can improve the vesicular properties 
when compared to conventional liposomes. 
Since the type of phospholipids selected for liposome preparation plays an 
important role for our investigation of emulsifier effect, the ideal liposomes which 
are deemed appropriate should consist of uncharged phospholipids, making them 
neutral liposomes and thus exhibit a noninterfering effect to added emulsifier. In 
addition, our ideal liposomes should have, at least, increased drug entrapment and 
high membrane elasticity of lipid bilayer for better penetration through deeper skin. 
While many strategies exist to enhance drug penetration, one of the most interesting 
which constitutes whole studies of this dissertation is the surface modification on 
lipid bilayer. 
Notwithstanding the fact that prior studies have demonstrated the surface 
modifications using either nonionic surfactant (Tween® and Span®) or long chain 
polymeric surfactant incorporated into lipid bilayer could enhance the elasticity of 
bilayer and drug penetration of liposomes [1, 2], other interesting substances for 
improving the drug penetration capacity are yet to be thoroughly observed. 
In the light of the above, we therefore tested a set of chosen emulsifiers in 
order to investigate their influence on drug permeation capability and membrane 
elasticity of liposomes. We divided these emulsifiers into four groups based on their 
characteristics: 1) charged phospholipids/surfactants, 2) sugar derivatives 
(carbohydrate-based surfactants), 3) polymeric surfactants, and 4) terpenes. Using 
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biological testing methods, i.e., ex vivo skin penetration and tape stripping on 
abdominal human skin obtained by plastic surgery, we are able to systematically 
categorize the enhancement capability of all tested liposomes. All in all, our studies 
would not only result in a valuable suggestion for further topical application, but 
also point out some liposomal formulations which have a high, promising potential 
for being a candidate for further advanced researches in this field. 
Aims of this research 
Even though, as mentioned earlier, dermal drug delivery has advantages over other 
routes of administration, it has also one major obstacle, the main barrier of the skin 
or the stratum corneum (SC), which is to be overcome as the aim of this research. 
Barrier features of SC limit drug transport therefore making it a less attractive mode 
for delivery of medications. In order to effectively across the skin, drug carriers 
must be able to pass not only through corneocytes but also in between them (via 
intercellular spaces). As a result of which, we have to modify our liposomes by 
incorporating them different emulsifiers (which are already divided into four 
groups), and then characterize the physicochemical properties and biological 
performance of those modified liposomes accordingly. At last stage, they will all 
be categorized based on their particular drug penetration capability. 
Therefore, the aims of the whole study can be divided into four parts, albeit 
interconnected themes, as follows: 
1) To compare the physicochemical properties and skin penetration study of 
carrier systems with five different phospholipid types. 
Five phospholipids (PL90G, NAT8539, LPC20, SUN70P and SUN90P) were 
used for preparing liposomal formulations. Hydrophilic dye, 
carboxyfluorescein was entrapped in the aqueous core. All phospholipids are 
unsaturated, having one to two double bonds in the fatty acid tails. They are 
mainly composed of difference percentage of phosphatidylcholine (PC) and 
other residuals. Liposomes can be normally and in practical formed with PLs 
containing more than 80% PC. 
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2) To study the influence of the addition of a charge into liposomes on the 
physicochemical properties and skin penetration study of liposomes. 
One of the factors affecting to skin penetration is the surface charge of 
liposomes. Positive or negatively charged liposomes entrapping CF were 
prepared using PL90G, in combination with brassicyl isoleucinate esylate 
(EM), quaternary ammonium (QA) or DSPG, DSPS. Liposomal formulations 
were characterized by dynamic laser light scattering for size distribution and 
polydispersity index (PDI), and electrophoretic mobility for zeta potential 
determination. In order to obtain more information about skin penetration, 
Franz’s cell diffusion technique was employed. 
3) To investigate the effect of surface modification of liposomes with 
hydrophilic polymer on the physicochemical properties and skin 
penetration study of liposomes. 
As the result of poor colloidal stability of liposomes, the incorporating 
hydrophilic polymers into liposomes can introduce a sterical barrier between 
adjacent bilayer membranes to prevent aggregation. In this study, two 
different groups: polyethylene glycol (PEG) series (PEG300, 600, 1000, and 
2000) and polyglycerol monooleate (PGMO) series (PGMO4, 5, and 10) are 
incorporated into lipid bilayer of liposomes. 
4) To study the effect of the surface modification of liposomes with sugar 
derivatives on the physicochemical properties and skin penetration of 
liposomes. 
The fourth and the last purpose of this study was to investigate the effect of 
sugar derivatives (sucrose oleate, SO; cetearyl glycoside, CG; polyglyceryl-3 
methylglucose distearate, TE) incorporated in lipid bilayer of liposomes on 
the physicochemical properties and skin penetration efficacy of liposomes. 
These selected sugar derivatives are usually used as emulsifying agent for 
topical formulations. 
References 
1. Cevc, G., et al., Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration 
resistance and transport therapeutic amounts of insulin across the intact mammalian skin. 
Biochimica et Biophysica Acta (BBA) - Biomembranes, 1998. 1368(2): p. 201-215. 
2. Knudsen, N.O., et al., Calcipotriol delivery into the skin with PEGylated liposomes. Eur J Pharm 
Biopharm, 2012. 81(3): p. 532-9. 
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Background information 
1. Structure and function of human skin 
Skin is the largest organ of human body, accounting for approximately 16% of total 
body weight [1]. Its main vital function is to prevent loss of water of the body to 
the environment and protect the body from a variety of environmental insults as 
described in Figure 1 [1, 2]. Furthermore, skin also has important immune and 
sensory functions, helps to regulate body temperature, and synthesizes vitamin D 
[3, 4]. The structure of skin and its barrier function have been extensively described 
in the literature [5]. 
1.1 Structure of human skin 
Human skin is composed of three layers, the epidermis, dermis and subcutaneous 
fat as illustrated in Fig 1. 
 
Figure 1 Structure and function of human skin (Source from Venus et al., 2011) [1]. 
1.1.1 Epidermis 
Epidermis is divided into several layers, all of which can be categorized into non-
viable epidermis and viable epidermis. The upper layer of the epidermis is the non-
viable stratum corneum (SC), which constitutes the main barrier function of the 
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skin. Underneath the viable epidermis is located, which is classified into three 
separate layers; stratum granulosum, stratum spinosum and stratum basale just 
above the dermis proceeding upward through the prickle and the granular layers to 
the top layer, the SC. It ranges in thickness from 75 to 150 µm [6]. Figure 2 is a 
diagram representing the major strata of the epidermis. The predominant cell type 
of the epidermis is the keratinocyte.  
Keratinocytes synthesize keratin and many other proteins. Keratins are the 
major structure proteins of the SC. In addition, there are two other cell types in the 
epidermis, which also play a significant role: melanocytes (which involve in skin 
pigmentation) and Langerhans (which relate to antigen presentation and immune 
response) cells [3, 5]. 
 
Figure 2 Diagram of the epidermis showing the main layers ( Source from Wickett and 
Visscher, 2006) [3]. 
1.1.2 Dermis 
Dermis has generally various in thickness, ranging from 0.6 mm on the eyelids to 3 
mm on the back, palms and soles. It is composed of a tough and supportive cell 
matrix which contains collagen and fibrous proteins embedded in a semigel matrix 
(water, hyaluronic acid, ions and mucopolysaccharides) [3, 5]. 
There are two layers, a thin papillary layer and a thicker reticular layer, 
which comprise the dermis. The papillary layer contains thin loosely arranged 
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elastics collagen fibers and is an important layer for the nutrition of the epidermis. 
Thicker bundles of collagen run parallel to the skin surface in the deeper reticular 
layer, which extends from the base of the papillary layer to the subcutis tissue. The 
dermis is made up of fibroblasts, which produce collagen, elastin and structural 
proteoglycans, together with immunocompetent mast cells and macrophages. Up to 
70% of the dermis are collagen fibers, giving it strength and toughness. Elastin 
maintains normal elasticity and flexibility while proteoglycans provide viscosity 
and hydration [3, 5]. 
1.1.3 Subcutaneous layer 
The subcutaneous layer or hypodermis is the innermost and thickest layer of the 
skin. It is located underneath the dermis and composed of a type of cell specialized 
in accumulating and storing fats (adipocytes). These cells are grouped together in 
lobules separated by connective tissue. This layers acts as energy storage, protect 
against injury and participates in thermoregulation (since fat is a heat insulator). It 
can act as a depot for lipophilic compounds, which permeate the dermis and SC [3, 
5]. 
1.2 Skin functions 
a) Barrier function: Skin prevents both excessive water loss from the 
body and the ingress of xenobiotic [6]. 
b) UV protection: Melanocytes, located in the basal layer produce melanin 
has an important role in preventing damages in the skin caused by UV 
radiation. In the inner layers of the epidermis, melanin granules form a 
protective shield over the nuclei of the keratinocytes; in the outer layers, 
they are more evenly distributed. Melanin absorbs UV radiation, thus 
inhibiting the formation of free radicals and protecting 
deoxyribonucleic acid (DNA) damages [1, 7]. 
c) Thermoregulation: The skin plays an important role in maintaining a 
constant body temperature through changes in blood flow in the 
cutaneous vascular system and evaporation of sweat from the surface 
[7]. 
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2. The barrier of human skin 
2.1 Formation of the SC barrier 
The stratum corneum (SC) is seen as a wall-like structure with protein bricks and 
lipid mortar [6, 8] as shown in Figure 3. The SC corneocytes, together with their 
resistant cell envelopes and keratin microfibrils are considered to be the bricks, and 
the layers of lipids found between the cells are considered to be the mortar [3, 9]. 
2.2 The bricks and mortar model of the SC barrier 
The lipid “mortar” is the main barrier preventing water passing through the SC [10]. 
Both the bricks and the mortar of the SC are produced by keratinocytes at the 
stratum granulosum (SG). Keratinocytes release the lipids of the mortar into the 
space between the cells as they are being transformed into corneocytes “bricks”. A 
major difference between the current and the earliest version of the wall model is 
that the bricks are linked by desmosomes as illustrated in Figure 3. 
 
Figure 3 “Bricks and Mortar” model for human stratum corneum illustrating the corneocytes 
“Bricks”, the intercellular lipid “Mortar”, and the desmosomes connecting the corneocytes (Source 
from Wickett and Visscher, 2006) [3]. 
2.2.1 The bricks (corneocytes) 
Keratinocytes move apically from basal layer to the skin surface in about 14 days, 
by a process called “desquamation” [11]. Epidermal differentiation begins with the 
migration of keratinocytes from the basal layer, and ends with the formation of the 
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cornified layer (SC). In epidermis differentiation, cell proliferation, differentiation 
and death occur sequentially, and each process is characterized by the expression 
of specific proteins. In normal epidermis, the proliferation rate in the basal layers is 
precisely balanced by desquamation of the cornified layer at skin surface. The 
epidermal homeostasis constantly rejuvenates the epidermis [12]. The corneocytes 
(terminally differentiated keratinocytes) are dead cells filled with keratin [13, 14]. 
The process of terminal keratinocyte differentiation gives rise to a 
cornified cell envelope forming beneath the plasma membrane. The cornified 
envelope provides a vital physical barrier to these tissues in mammals and consists 
of a 15 nm thick layer of highly cross-linked insoluble proteins. The assembly of 
the cornified envelope starts in the upper spinous layers of the epidermis. Involucrin 
is an early substrate for transglutaminase activity following by loricrin, cystatin and 
small proline-rich proteins (SPRs). Especially, loricrin and cystatin A are major 
constituents of the cornified envelope [15, 16]. 
2.2.2 The mortar 
The lamellar bodies appear at the SG contain lipids, which are released into the 
intercellular space of the SC. These lipids are glucosyl ceramides, cholesterol, 
cholesterol esters, and long chain fatty acids. In the intercellular space, the glucosyl 
ceramides are converted to ceramides [17]. The lipids spontaneously organize into 
multiple layers between the SC cells [18]. 
The SC contains virtually no phospholipids [19]. The phospholipids from 
the keratinocytes in the viable layers are broken down by phospholipases [19] in 
the lower SC. This enzymatic process produces fatty acids, which are necessary for 
the development of functional SC barrier and may play a role in producing the acid 
pH of the SC. The SC has a surface pH of approximately 4 to 5.5. This so-called 
“acid mantle” of the skin [20], plays a role in preventing colonization of harmful 
bacteria [21]. 
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2.2.3 SC desmosomes 
Desmosomes are structures composed primarily of glycoproteins, joining 
corneocytes in the SC together. Since they are modified from those located in the 
epidermis by the addition of a protein called “corneodesmosine” [22], therefore 
they are sometimes referred to corneodesmosomes. In the deeper layer of SC, 
desmosomes are more and intact, but they are gradually digested by the time at the 
skin surface [3]. 
In summary, the specialized role ‘brick and mortar’ of the SC works 
together to produce a cover for the skin that is both flexible and superbly protective. 
If the SC is functioning properly, it will effectively defend the body against 
dehydration, external toxins, and bacterial assault as well as protecting the more 
fragile keratinocytes below from mechanical disruption [21, 23]. 
3. Permeation through the skin 
3.1. Transappendageal route 
There are various potential pathways for permeation through the SC. Here we 
consider firstly the “transappendageal route”. It comprises transportation via the 
sweat glands and along hair follicles with their associated sebaceous glands as 
shown in Figure 4 [6, 24]. 
 
Figure 4 Possible routes for penetrant through the skin, 1: via the sweat glands; 2: across the 
continuous stratum corneum; 3: via the hair follicles with their associated sebaceous glands (Source 
from Barry, 2001) [25]. 
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This route involves penetration through the hair follicles. Since the hair 
follicles constitute only 0.1% of the total area of human skin, this route is normally 
not considered to be significant for permeation. It is of some importance for 
targeting actives to the hair follicles [26], however. 
3.2 Transepidermal pathway 
The “transepidermal route” across the SC between the appendages comprises 
transportation via 1) the intercellular route through lipid layer or 2) transcellular 
through the cells themselves [24, 25, 27] as depicted in Figure 5. The first pathway, 
the intercellular route, is a continuous and also tortuous way through the 
intercellular lipid domains. The intercellular spaces are filled with two layers. One 
of these layers contains lipids region (ceramides, sterols, sterol esters) and free fatty 
acids, which are organized in multilaminated sheets and other layer contains 
aqueous region.[28]. 
 
Figure 5 Suggested routes of transepidermal drug transport through human stratum corneum 
which has two micropathways; intercellular and transcellular routes (Source from Barry, 2001) [25]. 
However, the bilayers in the intercellular space in SC consist of straight 
closely packed and almost saturated hydrocarbon chains, resulting in 
impermeability. This route is widely accepted and regarded as the dominant 
pathway during steady-state permeation of compounds.[29]. The second pathway 
is the transcellular and requires diffusion through the keratinocytes and across the 
intercellular lipids. The intracellular spaces of corneocytes is highly dense and 
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virtually packed with structure protein [8]. All components of the intracellular 
spaces contribute to the barrier function of the SC. 
Nevertheless, there possibly are deviations in this basic structure of the skin 
that can affect the percutaneous absorption of penetrants. Some of these deviations 
are due to species differences, regional skin site variations, skin age and skin 
condition variables [30]. 
4. Penetration of substances 
Besides the structure of the barrier, other factors of the drug also play an important 
role for investigating percutaneous absorption. The important factors include the 
partition coefficient and the diffusion coefficient [6]. These factors depend on 
variables such as molecular weight, size, structure, pH and degree of ionization of 
the penetrants [6, 31-34]. In general, drug permeation across the skin requires drug 
substances with a molecular weight smaller than 500 Da and with an adequate 
partition between octanol and water (a log P value of 1-3) [35, 36]. The chemical 
structure of the penetrant is of importance in determining the permeation through 
human skin. The explanation and investigation of the percutaneous absorption of 
penetrant by one or the other factors are very difficult [24, 37]. In consequence, 
only general statements can be classified and based on homologous series of 
compounds, such as n-alkanols [24, 30]. 
As the barrier for percutaneous absorption is located in the SC for the majority 
of drugs, this study will be focused mainly on permeation through the SC which 
can be described using Fick’s first law (as shown in Equation 1).  
𝐽 =  
𝐷𝑆𝐶 .C𝑆𝐶
𝐿
 .
C𝑉
𝐶𝑆,𝑉
   Equation 1 
Where L is the diffusion pathway given by the thickness of the SC. The CV is the 
concentration of drug dissolved in the vehicle and CS, V is the solubility of the drug 
in the vehicle. 
This equation can predict the flux (J) across the SC based on solubility (CSC) 
and diffusion (DSC) of a substance [24, 38]. The influence of the SC thickness 
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involves the following: a) penetration of the drug from the vehicle into the SC, b) 
diffusion through the SC and c) penetration into the viable epidermis [24, 30, 39]. 
The role of concentration gradient in driving percutaneous absorption is 
considerable, where concentration in the outermost layer like SC is high followed 
by a decrease as we move to the deeper layer. This implicate the role of partition 
coefficient in the ability of the penetrant to reach the SC [40]. 
4.1. Chemical penetration enhancers 
The use of chemical penetration enhancer in dermal/ transdermal drug delivery 
plays an important role for better enhancement of drug through skin barriers. There 
is a set of various chemical structures that have been reported as skin penetration 
enhancer, e.g. fatty acids, fatty alcohols, terpenes, pyrrolidones, and surfactants [41, 
42]. The difference in chemical structures and physicochemical properties of these 
substances also affects their penetration enhancement capability [41]. Therefore, 
the correlation between the chemical structure and skin penetration enhancement 
activity has been studied and expressed in terms of structure-activity relationship 
(SAR) [41]. In our studies, we will examine the SAR of two groups of chemical 
penetration enhancers – surfactants and terpenes – and evaluate their skin 
penetration activities using ex vivo skin penetration method. 
4.1.1. Surfactant 
Surfactants are surface-active molecules and contain a hydrophobic moiety, usually 
alkyl chains or aryl moieties referred to as tail and a hydrophilic head group [43, 
44]. The schematic illustration of a surfactant molecule is shown in Figure 6. 
Surfactants are classified primarily by the characteristics of the headgroups. There 
are four major categories of surfactants based on the charge of the headgroup 
which are anionic, cationic, amphoteric, and nonionic. These are utilized as 
emulsifiers for the production of cream and cleansing purposes. 
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Figure 6 The basic molecular structure of a surfactant molecule 
In the present, the use of surfactant has gradually increased in liposome 
technology in particular the incorporation of surfactant into lipid bilayer for 
enhancing the flexibility property of vesicle. Many surfactants, e.g. Tween80®, 
Span80®, and sodium cholate, have been reported that they could increase drug 
solubility and enhance drug penetration through the skin as compared to 
conventional liposomes [41]. The capability of each surfactant for improving 
flexibility of lipid bilayer and enhancing drug penetration depends on the chemical 
structure and physicochemical property [41], e.g. molecular weight and 
hydrophilicity-lipophilicity property. In addition, effect of headgroup size and fatty 
acid chain length of surfactant on the percutaneous penetration enhancement of 
drug has been discussed in several reports. Mishra et al (2007) investigated the 
effect of a series of Span® (40, 60 and 80) on the transdermal flux of propranolol 
hydrochloride through male albino rat skin using elastic liposomal formulations. 
The maximum permeation was observed with Span®80 [45]. Hashizaki et al. (2003) 
investigated the effect of PEG chain length of the PEG-lipid on the phase transition 
of liposomes and temperature dependency of CF permeability from liposomes [46]. 
Surfactant molecules are known for their ability to disturb the lipid bilayers 
and bind to proteins, causing changes in their structure, and have been shown to 
bind to the SC as well. After binding to the protein, surfactant causes swelling of 
the SC. Presumably, corneocytes were separated widely with small regions of cell 
to cell contact and their membranes appeared denuded of intercellular lamellar 
bilayers [47]. There is a good correlation between degree of swelling and the 
harshness of surfactant (individual or mixture). The effect of various charges on the 
SC has been studied in detail. The ionic surfactants interact with keratin in 
corneocytes and disorder lipid bilayer of SC. While non-ionic surfactants can 
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enhance penetration with two mechanisms: first, surfactants penetrate into the 
intercellular spaces of SC to increase fluidity of bilayer and second, they can 
interact and bind with keratin protein in corneocytes. Not only charge of surfactants 
affects to enhance drug permeation, but also lipophilicity of them. High lipophilic 
surfactants interact with lipid and open the lipid bilayers of SC and high hydrophilic 
surfactants expand the water channels between the lipid bilayers. The lipid mortar 
is the major barrier to permeability of the SC, and surfactants are known to increase 
the ability of exogenous compounds to penetrate the skin and to increase the rate of 
water loss through the skin, presumably because of their effects on the lipid SC 
[48]. 
The effect of surfactant; sodium dodecyl sulfate, on SC lipids in pig skin 
exposed in vitro at 46 °C showed that the surfactant could disrupt the barrier lipids, 
induce intercellular lamellar bilayer disruption, and produce corneocytes separation 
[47]. Furthermore, Warner et al. (1999) found that water alone also disrupt the SC 
barrier lipids with a slower onset and enhanced permeation, as the result causing 
the intercellular lamellar bilayer disruption [47]. Besides, Blank (1953) reported 
water as a key factor for maintaining the pliability of the SC and showed that well-
hydrated SC is very flexible [49]. 
4.1.2. Terpenes 
Terpenes – naturally found in essential oils – are a very safe and effective class of 
penetration enhancers, obtained from natural sources, the FDA classifies them as 
generally regarded as safe (GRAS) [50]. Terpenes are compounds consisting of 
isoprene (C5H8) units [41, 51]. They are classified according to the number of 
isoprene units as monoterpenes (C10), sesquiterpenes (C15), and diterpenes (C20) 
[41]. Terpenes have been widely evaluated as skin penetration enhancers for 
various drugs, e.g., 5-fluorouracil [52], indomethacin [53]. Both the mono- and 
sesquiterpenes are known to increase percutaneous absorption of compounds by 
increasing diffusivity of the drug in stratum corneum and/or by disruption of the 
intercellular lipid barrier [54]. 
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5. Vesicles as skin delivery system 
Vesicular systems such as liposomes, niosomes, transfersomes ethosomes, 
invasomes and elastic vesicles provide an alternative for improved skin drug 
delivery. In general, the walls of these vesicles consist of amphiphilic molecules in 
a bilayer conformation. Due to an increase hydration, these amphiphilic molecules 
can form spontaneously one (unilamellar vesicles) or more (multilamellar vesicles) 
concentric bilayers. Hydrophilic drugs can be entrapped into the internal aqueous 
compartment, whereas amphiphilic drugs and lipophilic drugs can be associated 
with the vesicle surface and lipid bilayer by hydrophobic and/or electrostatic 
interaction [47]. 
In last decades, most of the conventional liposomes were composed of PC, 
cholesterol and entrapped substances. When applied these liposomes to skin for 
topical drug delivery, they deposit in the upper layers of the SC or pilobaceous unit 
and are not penetrated into deeper skin [48]. Therefore, the new generation of 
liposomes has been developed for better drug penetration through the skin. In 1992, 
the first type of deformable liposomes, i.e. the ‘Transfersomes®’, was introduced 
by Cevc and his colleagues [42]. These vesicles are composed of PC and sodium 
deoxycholate as the “edge activator” in lipid bilayer. They claimed special feature 
that such vesicles could pass through the SC by squeezing through skin pores that 
are less than one-tenth the diameter of liposomes. (We will discuss in detail about 
the deformable liposomes in 5.2.2 Deformable liposomes.) A wide variety of lipids 
and surfactants can be used to prepare vesicles, which are commonly composed of 
phospholipids (liposomes) [49] or non-ionic surfactants (niosomes) [50]. 
Furthermore, Fahr and his colleagues developed another type of deformable 
liposomes, i.e. ‘invasomes” composed of phosphatidylcholine, ethanol and mixture 
of terpenes (instead of other surfactants) as penetration enhancers [51]. Another 
kind of vesicle is ethosomes, which are composed of phospholipids and high 
content of ethanol (20–45%) [52]. The composition of the vesicles influences their 
physicochemical characteristics such as size, charge, thermodynamic phase, 
lamellarity and bilayer elasticity. These physicochemical characteristics have a 
significant effect on the behavior of the vesicles and hence on their effectiveness as 
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a drug delivery system. The rationale for using vesicles in dermal and transdermal 
drug delivery has many advantages [36, 53] as follows: 
1. Vesicles act as drug carriers to deliver entrapped drug molecules into 
or across the skin; 
2. act as penetration enhancers owing the penetration of the lipid 
components into the SC and subsequently the alteration of the 
intercellular lipid lamellae within this skin layer; 
3. serve as a depot for sustained release of dermally active compounds; 
and 
4. serve as a rate-limiting membrane barrier for the modulation of 
systemic absorption, hence providing a controlled transdermal delivery 
system. 
5.1. Mechanisms of action of liposomes as skin drug delivery systems 
Mechanisms have been suggested for liposomes acting as skin drug delivery 
systems as shown in Figure 6. 
 
Figure 6 Possible mechanisms of action of liposomes as skin drug delivery systems. A: the free 
drug mechanism, B: the penetration enhancing process with liposomes components, C: vesicles 
adsorption and fusion with the SC, and D: intact vesicle penetration into skin (Source from El 
Maghraby et al., 2006) [54]. 
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5.2. Liposomes as dermal drug delivery systems 
Bangham and colleagues in 1965 were the first to introduce the liposomes as drug 
delivery vehicles [49]. Liposomes are spherical vesicles with concentric 
phospholipid bilayers, which they are hydrophilic on one side and lipophilic on the 
other side. When phospholipids – having one hydrophilic headgroup and double 
fatty acid chain i.e., PC – are placed in water and obtain sufficient energy, this 
results in the arrangement of lipids and spontaneous formation of bilayer vesicles 
[55] as described in Figure 7 [56]. The amphipathic character of phospholipids 
allows entrapment of hydrophilic substances into the aqueous core and lipophilic 
ones in the lipid bilayer. 
 
Figure 7 The simplified mechanism of liposomes formation (Source from Mozafari et al., 
2008) [56]. 
These vesicles are preferred over other formulation because of their 
characteristics such as biocompatible, biodegradation, capacity of encapsulating 
both hydrophilic and lipophilic molecules, enhancement of solubility of hydrophilic 
and lipophilic drug, reducing the drug toxicity, increasing drug bioavailability and 
targeting delivery to skin appendages in addition to their potential for transdermal 
delivery [57-59]. However, the limitations of these vesicles are high cost of 
liposome production in large scale, instability and low entrapment of drug 
molecules into vesicles. Additionally, conventional liposomes remain confined to 
the upper layer of the SC and accumulate in the skin appendages, mainly owing to 
their large size and lack of flexibility [60]. Table 1 [61, 62] described liposomes 
classification based on their structure with size and number of lipid bilayers. 
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Table 1 Vesicle types of liposomes with their size and number of lipid layers 
[62, 63]. 
Vesicle type Abbreviation Diameter size 
No. of lipid 
bilayer 
Multilamellar 
vesicle 
MLV 500 nm - 10µm -25 
Small Unilamellar 
vesicle 
SUV 20-100 nm 1 
Large Unilamellar 
vesicle 
LUV More than 100 nm 1 
Giant Unilamellar 
vesicle 
GUV 10-1000 µm 1 
Oligolamellar 
vesicle 
OLV 0.1-1 µm Approx. 5 
The lack of stability and low drug entrapment (volume) of SUVs make them 
less suitable for drug delivery system. Magnitude of vesicle diameter is an 
important feature deciding penetration/ permeation of drugs through the topical 
route. Since too much increase of diameter may result in decrease of penetration 
through skin, the proper size of structure for this route of administration is therefore 
the LUVs having 50-300 nm Diameter size.[62]. 
Besides classifying by their structure, liposomes can also be classified based 
on their compositions. The first class of vesicles so called ‘conventional liposomes’ 
can be prepared with any types of phospholipids. Various types and purities of 
phospholipids are used in liposomal formulations [53]. Conventional liposomes in 
the past composed of mostly one or more phospholipids and cholesterol. In 1980, 
Mezei and Gulasekharam reported that liposomal triamcinolone acetonide 
(Multilamellar liposomes composed of DPPC and cholesterol) showed higher drug 
deposition in rabbit skin as compared with control lotion [64]. In order to overcome 
the limitation of low penetration of drug and drug deposition in superficial skin, 
drug carriers must pass through a very fine pores with an average diameter typically 
around ≤ 30 nm, under the proper transdermal gradient [65]. This approach has 
resulted in two novel designs of vesicular carriers, ethosomes and elastic vesicles 
(transfersomes). In 1997, ethosomes were introduced, which are composed of 
phospholipids, water and high amount of ethanol [66]. Indeed, ethanol cause the 
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carriers penetrate more easier into the deeper skin by fluidizing the lipid domain of 
SC [67]. Other vesicular system, Transfersomes, will be discussed in detail in topic 
5.2.2 (Deformable liposomes). 
5.2.1 Choice of lipids 
The choice of lipids for drug encapsulation into liposomes is dependent on the drug 
characteristics and intended applications. Liposomal composition determines the 
properties (including surface charge, rigidity, and steric interactions) and the in 
vitro and in vivo performance of liposomes. The specific properties of the liposomes 
are determined by the chemistry of the head and tail groups of the constituent lipids 
[68]. Liposomes can be prepared from a variety of neutral, cationic, and anionic 
phospholipids. Examples of these lipids include, PC [69] and 
phosphatidylethanolamines (PE) and phosphatidylserines (PS), 
phosphatidylglycerols (PG), phosphatidic acid (PA) and phosphatidylinositols (PI). 
At pH 7.4, PC has neutral charge, PE has positively charged while PS, PG, PA and 
PI have negatively charged [68]. Conventional liposomes can possess different lipid 
compositions; however, the most commonly used lipids are PC and cholesterol. 
An important property of phospholipids is the phase transition temperature 
(Tm). Tm determines the phase behavior of the liposomal membranes which in turn 
affects characteristics of liposomes such as permeability, fusion, and aggregation 
[70] .  The maximal release of drug is usually observed at temperatures below or 
close to the Tm of the lipid bilayer, where the bilayers transform from an ordered 
gel state into a more disordered liquid state [70]. 
There are several factors, which affect directly the phase transition 
temperature including hydrocarbon length, unsaturation, charge, and head group 
species. As the hydrocarbon length is increased, van der Waals interactions become 
stronger and require more energy to disrupt the ordered packing, thus the phase 
transition temperature increases. Introducing a double bond into the acyl group puts 
a kink in the chain which requires much lower temperatures to induce an ordered 
packing arrangement [71] .  The addition of cholesterol causes an ordering of the 
disordered fluid phase and therefore increasing amounts of cholesterol eventually 
lead to an elimination of the phase transition.  Consequently, liposomes containing 
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cholesterol are more adhesive, having high stability against proteins in vivo and 
against leakage of encapsulated materials. 
One major problem related to the use of liposomes in topical products is 
their poor colloidal stability.  One possibility to overcome such stability problems 
for liposomes is to coat them with hydrophilic polymers in order to establish a 
sterical barrier between adjacent bilayer membranes to prevent aggregation.  The 
effect of PEGylating liposomes for topical application was slightly described in the 
literature, however.  Only two relevant studies have reported the PEGylated 
liposomes application for topical drug delivery.  First, PEGylated liposomes can 
increase the skin permeation of zidovudine [72] .  Second, the D-vitamin analogue 
calcipotriol, pegylation of the saturated liposomes provided a significantly 
increased deposition of calcipotriol in the stratum corneum after topical application 
and an improved steric stabilization of liposomes [73]. 
A.) Phosphatidylcholine 
Phosphatidylcholine (PC) is the most abundant phospholipid in animal and plants 
[74] and the key building block of membrane bilayers. 
In addition to phosphatidylcholine, neutral lipid bilayers may be composed of 
sphingomyelin or alkyl ether lecithin analogues, which substitute entirely lecithin 
in the membranes. In sphingomyelin, the presence of the amide linkage and 
hydroxyl groups (in the region corresponding to the glycerol backbone of lecithin) 
gives rise to hydrogen bond interactions with its neighbors in the membrane [75]. 
B.) Charged phospholipids 
It is well known that skin may act as a negatively charged membrane; it has been 
generally reported that the presence of charge on the vesicle surface affects the drug 
diffusion through the skin. One of interesting strategies enhancing the stability of 
liposomes and influencing drug penetration is the modification of surface charge of 
liposomes. 
Previous studies have documented the modification by using charged 
phospholipids; coating liposomes with polymers and addition of charge induce 
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agents. Recently, Sinico et al. [76] have shown that negatively charged liposomes 
strongly improved newborn pig skin hydration and tretinoin retention as compared 
to both hydroalcoholic and oil solutions, though evidence of intact liposomes was 
not found. Gillet et al. [77] revealed that negatively charged liposomes significantly 
enhanced betamethasone penetration in the epidermis compared to positively 
charged and neutral liposomes, while negative non- liposomal dispersions were 
unable to enhance skin penetration.  On the other hand, Manosroi et al.  [ 78] 
demonstrated that positively charged liposomes produced a higher absorption 
amphotericin B through the SC than that negatively charged one. These results can 
be explained by the fact that the three possible forces affecting headgroup 
interaction of bilayer membranes can function, namely steric hindrance, hydrogen 
bonding and electrostatic charge [55, 64]. In summary, charge source (phospholipid 
or surfactant)  for liposomes have not been tested separately resulting in a lack of 
explanation for enhanced bioactivity of charged liposomes ( positively or 
negatively-charged) reported until now. 
Furthermore, liposomes coating with charged synthetic or natural polymers 
have been attempted to enhance permeation. Hasanovic et al. [79] examined the 
influence of adding cationic polymers (chitosan or Eudragit EPO) on the stability 
and skin penetration of DPPC liposomes encapsulating acyclovir or minoxidil. 
They showed an increased stability by the addition of the two different cationic 
polymers and an increased skin permeation of drugs from coated liposomes. Several 
polymers were coated on surface of liposomes for enhancing the permeation 
properties of drugs, for example, chitosan [80], poly(vinyl alcohol) [81] and 
Eudragit® series [79]. Despite enhanced stability of charged liposomal formulation 
and drug penetration enhancement through the skin, their human toxicity 
evaluations reveal skin drying [82] and irritation [83]. Therefore, charging agents 
require a more careful consideration from the perspective of liposomes 
biocompatibility and components added during the preparation. 
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5.2.2 Deformable liposomes 
In 1992, Cevc and Blume introduced the first generation of the highly deformable 
liposomes, elastic liposomes, referred to as Transfersomes® (IDEA AG, Munich, 
Germany) composed of PC and sodium cholate [53, 84]. Deformable liposomes 
mainly consist of phospholipids especially soybean PC [85, 86] that is an 
unsaturated phospholipid (PL) and surfactant (sodium cholate, sodium 
deoxycholate [87-90]) that acts as an ‘edge activator’ capable of destabilizing the 
lipid bilayer thus increasing its deformability. The reason for using unsaturated PLs 
for preparing deformable liposomes is that they form bilayer in liquid crystalline 
phase. Because of the kinks in the carbon chains at the cis double bonds of 
unsaturated fatty acids, the PL molecules do not fit closely together which in turn 
imparts certain flexibility to the bilayer membrane. Use of unsaturated PL and edge 
activator together are responsible for the highly deformable nature of 
Transfersomes. 
In principle, deformable liposomes can accommodate any kind of 
molecules: very lipophilic substances are incorporated into lipid bilayer; water 
soluble compounds find shelter in the aqueous vesicles core; and amphiphatic 
molecules typically adsorb to the lipid-water interface. In case of large molecules, 
such as protein, these liposomes can encapsulate such a large macromolecule into 
vesicles using a combination of several interactions. Thus, the capacity of 
deformable liposomes to accommodate many types of molecules proves their utility 
for dermal drug delivery system. 
Deformable liposomes can penetrate through SC in two ways. First, 
vesicles can act as drug carrier systems, whereby intact vesicles enter the SC 
carrying vesicle-bound drug molecules into the skin. Second, vesicles can act as 
penetration enhancers, whereby vesicle bilayers enter the SC and subsequently 
modify the intercellular lipid lamellae. These mechanisms facilitate penetration of 
free drug molecules into and across the SC [91, 92]. 
Cevc et al. (1995) reported that Transfersomes having an average diameter 
500 nm are able to pass through the smaller polycarbonate membrane pores 5 times, 
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in spite of the large size difference between the vesicles and water characteristic 
dimensions in both systems as shown in Figure 8 (A) [85]. 
A) B) 
 
Figure 8 A) Relative permeation capability of the Transfersomes through the narrow pores 
under the influence of a trans-pore pressure difference (Source from Cevc et al., 1995) [66]. B) 
Hydration gradient (This gradient drives from high to low level) and deformability-driven movement 
of Transfersomes through small pores (Drawn from Cevc et al., 1996) [93]. 
Topically applied Transfersomes dehydrate on the skin surface by 
evaporation and thus an osmotic pressure difference is originated between the 
highly hydrated regions inside the skin and the dehydrated skin surface, which 
makes Transfersomes enter the SC moving into the deeper skin to avoid 
dehydration [94, 95] .  Transfersomes require a hydration gradient to support skin 
penetration, that is, non-occlusive condition.  Then the gradient operating from the 
dry skin surface towards waterlogged viable tissues drives Transfersomes through 
the SC (Figure 7 (B)) [93]. 
Using confocal laser scanning microscopy, Schatzlein and Cevc ( 1998) 
suggested two different penetration pathways in the SC. An intercluster route with 
low penetration resistance, where lateral inhomogeneity in the SC showed ‘clusters’ 
consisting of groups of 3 to 10 corneocytes.  The other pathway was an 
intercorneocyte pathway that was more resistant to the penetration and was more 
abundant [ 96] .  Within the intercellular lipid lamellae, these regions contain 
structural irregularities that can act as ‘ virtual channels’  through which the 
deformable liposomes can penetrate because of their high flexibility owing to the 
edge activator molecules [96]. 
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5.2.3 Surfactant as edge activator for deformable liposomes 
Edge activator is often a single chain surfactant; its incorporation within the bilayer 
can destabilize the bilayers by increasing the radius of curvature of the bilayers 
which in turn also increases the deformability of the vesicles [97]. Ratio of an edge 
activator with the phospholipid is not fixed but usually varies with formulation 
requirements. Therefore, the concentration of each edge activator is systematically 
tested in order to search for suitable concentration which provides highest skin 
penetration while still maintaining adequate stability and drug loading. 
6. Liposomes in dermatology 
The advantage of the liposomal formulations over conventional dermatological 
formulations was particularly striking when the activity of local anesthetic agents 
was evaluated in cream, ointment or lotion forms versus liposomes. A liposomal 
containing 0.5% tetracaine exhibit more intensive activity (6-8 folds) than 1.0% 
tetracaine in commercial Pontocaine® cream [98, 99]. Similar results were obtained 
with liposomal formulations of another local anesthetic agent, e.g. lidocaine 
(Maxilene®) [100-102]. 
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Materials 
1. Materials for preparation of vesicles 
PL90G (Phospholipon® 90G from soybean, unsaturated, phosphatidylcholine > 
95%), DSPG (Distearoyl phosphatidylglycerol) and DSPS (Distearoyl-
phosphatidylserine) were kindly supplied by Lipoid GmbH (Ludwigshafen, 
Germany). Phosphatidylcholine (PC), purified soybean phosphatidylcholine (SPC) 
dissolved in ethanol (NAT8539, SPC: ethanol 75:25, w/w) was purchased from 
Phospholipid GmbH (Cologne, Germany). SUN70P and SUN90P, unsaturated, 
phosphatidylcholine purified from sunflower were kindly provided by Berg and 
Schmidt (GmbH & Co.) (Hamburg, Germany). 
Hydriol® OP.3 (Oleic acid-PEG300-ester), Hydriol® OP.6 (Oleic acid-
PEG600-ester), Hydriol® OP.10 (Oleic acid-PEG1000-ester) and Hydriol® OP.20 
(Oleic acid-PEG2000-ester) were gifts from Hydrior AG (Wettingen, Switzerland). 
Moreover, Hydriol® PGMO.4 (Polyglyceryl-4-oleate), Hydriol® PGMO.5 
(Polyglyceryl-5-oleate), and Hydriol® PGMO.10 (Polyglyceryl-10-oleate) were 
gifts from Hydrior AG (Wettingen, Switzerland). 
Emulsense® (Brassicyl Isoleucinate Esylate) was kindly provided by Inolex 
Chemical Company. TEGO® CARE 450 (Polyglyceryl-3 Methylglucose 
Distearate) and TEGO® CARE CG 90 (Cetearyl Glucoside) were supplied by 
Evonik Industries AG. Sucrose oleate was a gift from Mitsubishi Chemical 
Corporation. 
D-limonene, citral, 1,8-cineole, Tween80 and cholesterol were purchased 
from Sigma – Aldrich. 
2. Materials for permeation and penetration experiments 
Phosphate buffer solution (PBS) was composed of disodium hydrogenphosphate 
dehydrate (Na2HPO4·2H2O) (Roth, Germany), potassium dihydrogenphosphate 
(KH2PO4) (Roth, Germany), sodium chloride (NaCl) (Merck, Germany), potassium 
chloride (KCl) (Merck, Germany) and distilled water. 
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Carboxyfluorescein (CF) was purchased from Sigma-Aldrich (Steinheim am 
Albuch, Germany). All other chemicals used in this study were of analytical grade 
and purchased from Merck (Darmstadt, Germany) and used as a hydrophilic 
fluorescent marker. The molecular formula is C21H12O7 and molecular weight is 
376.32 g/mol. The chemical structure of CF is shown in Figure 9. 
 
Figure 9 Chemical structure of carboxyfluorescein; 3´,6´-Dihydroxy-1-oxospiro [2-
benzofuran. 
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Methods 
1. Preparation of human skin models 
Female human abdominal skin was kindly provided by Dr. Gruhl (Kassel, 
Germany) following plastic surgery. The subcutaneous fat tissue was removed from 
the skin using a scapel and surgical scissors as illustrated in Figure 10. The full-
thickness skin was obtained. Then, the skin was cleaned with PBS pH 7.4 and 
allowed to dry for about 20 min at room temperature. The prepared skin samples 
were wrapped in aluminium foil and stored at -20°C for later use. These samples 
have a shelf-life of 3 months for all experiments. 
 
 
Figure 10 Removal the fat tissue from human abdominal skin 
Before use, skin disks of 18 mm were punched out, cleaned with PBS (pH 
7.4, 10mM) and thawed with the stratum corneum (SC) side up open to the 
atmosphere and the dermal side bathed with PBS for 2 h. Subsequently, 
transepidermal water loss (TEWL) (VapoMeter, Delfin Technology Ltd., Kuopio, 
Finland) of the skin disks were visually inspected to ensure that disks were free 
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form any surface irregularity such as holes. All investigations were conducted in 
full compliance with ethical principles, i.e. the studies were reviewed and approved 
by the Ethics Committee of the Friedrich-Schiller University Jena. 
2. Preparation of liposomes 
The liposomes containing PC and surface modifier were formulated and prepared 
essentially by a sonication method [101]. Briefly, the appropriate amounts of 
phospholipids (10%w/w in case of phospholipid liposomes) and surface modifiers 
(charged inducer agents, PEG-monooleate, PG- monooleate, sugar derivatives and 
penetration enhancers) in ratio of 9:1 (lipid: surface modifier in weight) were 
completely dissolved in 1 ml of ethanol/ PBS (total concentration of ethanol 
16%w/w for all formulations), gently shaken for 2 min and then sonicated for 10 
min in 10 cycles with a sonication ice-water bath. CF-containing liposomes were 
prepared in a similar way, 30mM CF was added instead of PBS (total concentration 
of CF 0.087%w/v for all formulations). Then these liposomal suspensions were 
extruded through polycarbonate membrane (diameter: 19 mm, pore diameter: 100 
nm, Armatis, Schriesheim, Germany) 21 times with a Hamilton-Bonaduz extruder 
(GASTIGHT #1001, Bonaduz, Switzerland) to produce liposomes with 
homogenous sizes. 
3. Liposomes characterizations 
3.1 Particle size distribution and zeta potential measurement 
The particle size, polydispersity index (PDI) and zeta potential of all lipid vesicles 
were determined by photon correlation spectroscopy (PCS, Zetasizer Nano series, 
Nano-ZS, Malvern Instruments Ltd., Worcestershire, UK). Before size and zeta 
potential measurements, different liposome samples were diluted 20-times with 
filtered water prepared by using polycarbonate membrane (Minisart® syringe end 
filters 0.2 µm, Sartorious AG, Göttingen, Germany). Measurements were made at 
25 ˚C with a fixed angle of 137°. Sizes quoted are the z-average mean for the 
liposomal hydrodynamic diameter. 
The polydispersity index (PDI) was determined as a measure of homogeneity. 
Small values of PDI ( < 0.3)  indicate a homogenous population, while PDI  0.3 
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indicate high heterogeneity [ 102] .  For the measurement of zeta potential, the 
electrophoretic mobility of the dispersion was determined by laser Doppler 
velocimetry.  The zeta potential values were calculated by the Smoluchowski 
approximation of Henry’ s equation.  Calculation of zeta potential ( mV)  was done 
by the instrument from electrophoretic mobility. 
3.2 Deformability study 
The vesicle suspension was driven through a microporous filter by an external 
constant pressure of high pressure. The size of the vesicles was monitored by 
dynamic light scattering measurement before and after the filtration through a 
microporous filter with pore diameter 50 nm using a stainless steel pressure filter 
holder for 47 mm diameter filters, with 200 ml capacity barrel. Deformability value 
can be followed by the equation 2, which was developed by Bergh et al. (2001) 
[103]. 
D = J × (rv/rp)2 Equation 2 
Where J is the amount of vesicle suspension extruded (g) for 10 min, rv the size of 
vesicles after extrusion (nm) and rp the pore size of the barrier (nm). To measure J, 
the vesicles were extruded through a polycarbonate membrane (Nuclepore, 
Whatman Inc., MA, USA) with a pore diameter of 50 nm (rp), at a pressure of 2.5 
bar. After 10 min of extrusion, the extrudate was weighed (J), and the average 
vesicle diameter after extrusion (rv) was measured by dynamic light scattering 
(DLS). 
3.3 Percentage of Entrapment efficiency (%EE) 
Free carboxyfluorescein was separated from entrapped CF using an 
ultracentrifugation method. The liposomal suspension (0.5 ml) was added to an 
Eppendorf tube (1 ml) and centrifuged at 4 °C at 14,000 g for 30 min. The non-
entrapped CF in the filtrate was quantified the concentration by fluorescence 
spectrophotometry. Entrapment efficiency of CF was calculated indirectly from the 
amount of free CF, according to the following equation 3: 
Entrapment efficiency (%) = (1 – Cf/ Ct)  100 Equation 3 
with Cf as the amount of free CF and Ct as the total amount of CF. 
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3.4 Storage-stability studies 
Samples were stored in tightly capped tubes at room temperature for 90 days. 
Physical stability studies of liposome formulations were carried out to investigate 
the particle size and percentage of CF remained in liposomes during storage. 
Samples from each were taken at time intervals of 0, 30, 60, and 90 days. 
3.5 Skin permeability study 
3.5.1 Ex vivo permeability of carboxyfluorescein 
The skin samples were mounted in Franz diffusion cells under non-occlusive 
condition with the effective surface area of 0.5 cm2 and a receptor volume of 5.7 
ml. The dermal side of the skin was exposed to the receptor fluid and the SC 
remained in contact with the donor compartment left dry and open to the 
atmosphere. The temperature was maintained at 37 ± 0.1 °C, in order to maintain 
the skin surface at 32 °C, and the receptor solution was continuously stirred at 700 
rpm with a small bar magnet placed inside the cell. Five µl of each liposomal 
formulation were applied onto the skin’s surface and uniformly spread. Samples (1 
ml) were taken from the receptor fluid at 3, 6, 12 and 24 h after application. At each 
point, the receptor cell content was replaced by 1 ml of fresh solution. The samples 
were diluted to proper concentration before measuring the amount of CF by 
spectrofluorometer. Three replicates were used for the study. 
3.5.2 Ex vivo and in vivo tape-stripping of the stratum corneum 
The ex vivo and in vivo skin penetration studies were carried out by the tape 
stripping technique in a modified form after Coderch et al. (1996) [104]. Before 
this ex vivo measurement, the excised human skin was stretched and mounted with 
pins on cork discs and covered with aluminium mask with a central hole of 8 mm 
in diameter. In case of in vivo experiments, two volunteers were tested on their 
own both (left and right) sides of forearm and were applied the tested formulations 
with a circle-shaped of 8 mm. The applied volume of liposomal suspension for each 
experiment was of 5 µl.  
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After 2 hours, the SC was successively removed by stripping with an 
adhesive tape (CristallKlarTesa®, Beiersdorf AG, Hamburg, Germany). Each tape 
was put onto the skin and a weight of 2 kg was placed on the tape for 10 s. Afterward 
the tape was rapidly removed with forceps and transferred into a glass vial of 
suitable size. Fifteen stripping procedures were performed consecutively. One ml 
of ethanol/ PBS pH7.4 (1:1, v/v) was added to each vial to extract the CF from the 
strip. Each vial was vortexed for 2 min and then sonicated for 2 min, after which 
they were kept overnight at room temperature under light protection. The strips 
were analysed for CF content by fluorescence spectrophotometry. The results were 
expressed as percentage of the applied CF dose penetrated into the skin. 
3.5.3 Fluorescence assay of carboxyfluorescein 
The concentration of CF was determined by fluorescence spectroscopy. 
Fluorescence detection was performed at an excitation of 490 nm and an emission 
of 520 nm in the case of CF. The method was validated for linearity, accuracy and 
precision. The linear range during the measurements for CF was from 0.1 to 4.0 µM 
(r2 = 0.99). The software used was Optima, version 2.10, BMG Lab Tech. 
3.6 Data analysis 
All reported data are mean ± S.D. Statistical significance was interpreted by 
Student’s t-test using Graph Pad Prism® Ver.6 software and considered to be 
significant at P < 0.05. 
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1. Phospholipids selection for preparing model liposomes 
Phospholipids (amphipathic structure) are the main components for liposome 
production. Recently, various types of phospholipids have been used, each of which 
has advantages and disadvantages based on intended purpose of use. The purpose 
of this study was to examine the characteristics of phospholipids and select one 
model phospholipids which possesses preferable characteristics for further studies 
on surface modification of liposomes. 
Vesicle size, charge, membrane elasticity, entrapment efficiency and drug 
penetration are factors that influence skin penetration of the liposomes [1-3]. Hence, 
these parameters were considered for selecting model liposomes for this 
dissertation. The particle size, especially small size, is a desirable physical property 
of vesicles, as it could enhance the skin penetration of drug as compared to large 
vesicles [4, 5]. Zeta potential – a key indicator of the magnitude of charge carried 
by the liposome – helps in gauging the stability of colloidal dispersions and drug 
penetration [6]. Ogiso et al. (2001) have previously shown that that drug penetration 
can be influenced by modifying the surface charge of liposomes [7]. To this effect, 
Gillet et al. (2011) observed that negatively charged liposomes exhibit the enhanced 
penetration of betamethasone when compared with neutral liposomes and positively 
charged liposomes [8], however, Manosroi et al. (2004) suggested that the 
positively charged liposomes might be the best formulation for amphotericin B, due 
to the highest flux in stratum corneum and higher stability than other formulations 
compared to negatively charged liposomes [9]. These effects indicate that the 
performance of the liposomes cannot be simply explained by charge but by several 
of the other factors such as payload and method of preparation of the liposomes. 
In this study, we selected five phospholipids – namely PL90G, NAT8539, 
LPC20, SUN70P and SUN90P – to prepare liposomal formulations and investigate 
the physicochemical properties. Most natural phospholipids are mixed with the 
main component of the phospholipids being phosphatidylcholine (PC), lyso-PC and 
other residues (i.e., phosphatidylethanolamine (PE), phosphatidylinositol (PI), and 
phosphatidic acid (PA)) [1]. The selected phospholipids were derived from plant 
source and vary in components as represented in Table 3. Because of high 
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proportion of polyunsaturated fatty acid chains from plant source, these 
phospholipids are more flexible in lipid bilayer when compared to phospholipids 
extracted from egg yolk [1]. 
Table 3 Composition of different selected phospholipids [10]. 
Phospholipids %PC %Lyso-PC %Others 
PL90G > 95 < 1 - 
NAT8539 85 6 
PI = 1.5 
PE = 6 
PA = 2 
LPC20 32 50 
PI =4 
PE = 8 
PA = 3.5 
SUN70P 85.91 7.18 
PI = 0.59 
PE = 2.89 
PA = - 
SUN90P 40.07 16.54 
PI = 2.42 
PE = 2.22 
PA = 18.81 
PC (Phosphatidylcholine), Lyso PC (Lyso phosphatidylcholine), PI 
(Phosphatidylinositol), PE (Phosphatidylethanolamine), PA (Phosphatidic acid) 
1.1. Selected physicochemical characteristics of liposomes 
Physicochemical properties are a suitable indicator for the prediction of skin 
penetration efficiency of liposomal preparation. The evaluation of the 
physicochemical parameters of the liposomal formulations is a fundamental aspect 
to be investigated, due to their influence on the skin penetration behavior. The sizes, 
zeta potentials and deformability of the prepared liposomes are shown in Table 4. 
The particle size analysis revealed that the size of all prepared liposomes was in the 
range of 33.33 ± 0.36 nm to 174.93 ± 2.41 nm, indicating that the most of them 
were in range of small unilamellar vesicles (SUVs) [1]. 
The other observation showed that the size of L3 was the largest among the 
tested vesicles. This might be due to the higher amount of lyso-PC in LPC20, 
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resulting in an increased particle size. The polydispersity index (PDI) of the 
prepared liposomes had values from 0.03 ± 0.05 (high homogeneity) to 0.37 ± 0.01 
(lower and not in range acceptable homogeneity, since PDI < 0.3 [11]), indicating 
L5 had less homogenous population of vesicles as compared to the others. The zeta 
potential is related to the charge on the surface of the vesicle which influences both 
vesicular properties such as stability, as well as skin-vesicle interactions. In this 
study, L1, L4 and L5 possessed only a small negative surface charge and were 
therefore considered as neutral charge. Whereas L2 and L3 possessed a high 
negative surface charge (Table 4). 
Table 4 The selected physical characterizations and liposomal compositions of 
non-entrapped phospholipid liposomes by vesicle size, PDI, zeta potential and 
deformability. 
Rank 
Vesicle properties Zeta 
potential 
(mV) a 
Deformability 
index (D) a Size (nm)a PDIa 
1 174.93 0.37 -1.5 2.894 
2 95.29 0.28 -2.55 2.014 
3 69.48 0.22 -5.75 1.707 
4 65.37 0.22 -40.16 1.26 
5 33.33 0.03 -56.12 0.354 
 
Code L1 L2 L3 L4 L5 
Composition 
PL90G:EtOH
=10:16 
NAT8539:EtOH
=10:16 
LPC20:EtOH
=10:16 
SUN70P:EtOH
=10:16 
SUN90P:EtO
H=10:16 
 
Chosen for 
further studies 
All prepared liposomal formulations were tested for their deformability by 
extrusion measurements. Results are expressed in terms of deformability index (D-
value). This value is a unique parameter for elastic vesicles and represents the 
flexibility of vesicle membrane and stress-dependent adaptability. The minimum D 
value is ‘0’ indicating that liposomal formulation are not able to pass through the 
polycarbonate membrane (a skin pore analogue) (amount of filtrate; j = 0) with a 
given pore size. On the other hand, the maximum D value has no limitation value, 
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depending on the capability of formulation passes through the membrane. The 
deformability of liposomes is also affected by the type of phospholipids used, which 
could be interpreted by the differences in their chemical structures. The D value of 
prepared liposomes decreased in the following order: LPC20 > PL90G > SUN90P 
> NAT8539 > SUN70P. The optimum deformability for the formulation was 
observed in LPC20 phospholipids (L3). This may be due to the high amount of lyso-
PC (∼ 50%w/w). Since the molecules of the type lyso-PC having a polar headgroup 
and single chain gives the molecule an overall conical shape, higher flexibility if 
incorporated in lipid vesicles compared with PC having two long chain of 
hydrophobic acyl hydrocarbon and one hydrophilic polar headgroup [1]. 
1.2. Entrapment efficiency 
The physicochemical properties of CF entrapped liposomes are shown in Table 5. 
The vesicle size distribution of all CF entrapped liposomal formulations has a 
diameter size in the range of 43.58 ± 0.56 – 175.77 ± 2.41 nm. Almost all 
formulations (L2 - L4) were marginally larger in vesicle size. These results may be 
the reason that CF molecules could increase the whole volume of vesicle core. 
Another property is entrapment efficiency. The entrapment efficiency (EE) was 
expressed as a function of the percentage of cumulative CF released (Table 5). The 
EE of CF ranged from 25.48 ± 7.88% to 35.10 ± 3.89% obtained from different 
liposomal formulations. The highest %EE was achieved by the PL90G liposomes 
(L1). 
Table 5 Physicochemical properties of phospholipid liposomes entrapped 
with carboxyfluorescein (CF) 
Vesicle size (nm)a %Entrapment efficiency (%EE) a 
175.77 35.10 
82.21 30.77 
70.21 28.18 
44.6 27.12 
43.58 25.48 
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1.3. Ex vivo skin permeation study 
We investigated the delivery of CF into the ex vivo skin after topical application. 
Plots mean cumulative amount of CF released across abdominal fullskin from 
different liposomal formulations evaluated as a function of time are shown in 
Figure 12. The cumulative amount of CF released at 24 h, the liposomal 
formulations evaluated in this study in the decreasing order of their ability to deliver 
the CF across fullskin was formulation CF-L3 > CF-L1 > CF-L5 > CF-L4 > CF-
L2. 
 
Figure 12 Skin permeation of CF after 24 h non-occlusive application of different CF 
formulations onto human abdominal skin (expressed as % cumulative of dose released ± S.D., n=3) 
Comparison of the mean values using analysis of variance has revealed that 
they are significantly different (P < 0.05). Further, pairwise multiple comparison 
procedures (the Tukey’s test) have revealed that the CF released across full 
thickness skin into receptor compartment was significantly lower (P < 0.05) than 
from all prepared liposomal formulations. There is an important to note that the 
type of phospholipids for liposomal preparation on the physicochemical properties 
(size, zeta potential, deformability) and penetration behavior of CF. 
Even though, L3 shows the largest vesicles, it has the highest CF permeated 
through the fullskin. We speculate that the factors related to drug permeation 
enhancement not only include the phospholipid composition, but also particle size 
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and the interaction between lipid bilayer and deeper skin when penetrated through 
skin. However, these results disagree with Valenta and Janish (2003) who reported 
that small vesicles improved both deposition into and penetration through skin, with 
large vesicles improving deposition only [12]. NAT8539 and LPC20 liposomes 
exhibited high negative surface charge (Table 4) which eliminated them as the ideal 
candidates for the further study based on the minimum criterion decided – namely 
inability to clearly allocate the effects of surface modifications to the modifier or 
the native charge on the liposomes. On the other hand, SUN70P and SUN90P were 
observed to show low D values suggesting poor ability to penetrate to a great extent 
through the skin. We observed that among the liposomes synthesized PL90G 
exhibited an acceptable particle size, lowest negative zeta potential, high D value 
and high drug entrapment efficiency thus satisfying all criterion for our studies. 
Therefore, PL90G phospholipids was subsequently used for investigation of 
various surface modification treatments. 
Apart from giving us the selected model liposomes for further experiments, 
this experiment illustrated the effects of lyso-PC upon some physicochemical 
properties of liposomes (size, zeta potential and deformability). 
Table 7 Effect of LPC amount in PL90G phospholipid bilayer on characteristics 
of liposomes 
% Lyso-PC b 
Physicochemical properties 
Particle size (nm)a Zeta potential (mV)a Deformability (D)a 
3.2 67.21 ± 1.84 -10.18 ± 1.78 1.890 ± 3.22 
8 89.77 ± 1.98 -36.85 ± 6.23 1.987 ± 2.85 
16 120.65 ± 3.11 -48.12 ± 2.90 2.671 ± 1.89 
32 169.09 ± 2.09 -57.88 ± 0.78 2.849 ± 2.44 
a Average of three determinations ± standard deviation (SD) 
b Lyso-PC; lyso phosphatidylcholine 
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With respect to component of phospholipids, PC is one of main component 
and the other one being is lyso-PC. Their utility in effectiveness of the formulations 
required further the investigations by incremental quantitative changes in 
concentration in the preparations. The effect of the amount of lyso-PC in PL90G 
phospholipid bilayer was expressed as shown in Table 7. Interestingly, as we 
increased the concentration of lyso-PC into the vesicle bilayer, this resulted in 
increase in all the physicochemical parameters. We therefore concluded that lyso-
PC alters the physicochemical characteristics of the liposomes. Lyso-PC molecule 
is generally known to result in micelle formation [1] but in our investigation we 
observed that lyso-PC did not result in micelle formation, but rather (only in the 
presence of phospholipids) formation of liposomes. This effect could be ascribed to 
interference of lyso-PC molecule in packing of the intercellular lipid bilayer which 
resulted in altered fluidization and polarity of the bilayer. 
1.4. Conclusion 
The conceptual framework of this dissertation is focused at understanding the 
effects of surface modification during the preparation method for liposomes on their 
performance for efficient skin penetration/permeation. Native charge of 
phospholipid can interfere with ascertaining the true effect of emulsifiers upon 
liposome performance. In order for emulsifier properties to be investigated, we 
consider the "neutral liposome" (as defined by Gillet et al. 2011) [13] as an ideal 
liposome candidate for our experiment. This allows us to understand the effects of 
such modifications (tested eventually) on liposome’s characteristics and 
performance independent of the native charge possessed by the liposomes. Thus we 
propose that neutral liposomes are ideal candidates for estimation/ evaluation of 
effects of surface modifications. Membrane elasticity of liposomes is also one of 
the main parameters in addition to their size and surface charge discussed above. In 
order to investigate and compare the elasticity of our liposomes, all preparations 
were quantified and measured by their deformability index (D value) which enabled 
us to arrange our liposomes based on their membrane elasticity. A high value for 
this parameter represents high flexibility of the liposome membrane. Several studies 
have indicated a high deformability index can allow increased penetration 
efficiency for the claimed liposomes. 
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Based on these characteristics for our further studies we therefore define an 
ideal model liposome as 
1) preferable small size (in range of small unilamellar vesicles) 
2) neutral charge 
3) high deformability index and 
4) high drug entrapment efficiency 
Type of phospholipids for preparing liposomal formulation can have an effect 
on the physicochemical properties directly through alteration of diameter size, 
deformability, entrapment efficiency and drug release. Considering the results from 
all above criteria, among five phospholipids, PL90G liposomes (L1) were selected 
for further experiment in this dissertation because of their acceptable small size, 
neutral charge, high elasticity of vesicle membrane and high drug entrapment 
efficiency. 
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2. Influence of surface charge on drug penetration performance of 
liposomes 
For subsequent work of this dissertation we use PL90G phospholipid while 
emphasizing the importance of the neutral charge on the liposomes (phospholipid 
attributable). In order to estimate the actual impact of surface charge (independent 
of native charge) liposome selection stringency aids in pinpointing the actual charge 
related mechanism for effective drug penetration. 
Liposomes used for measuring the influence of surface charge on skin 
penetration were generated using distearoyl phosphatidylglycerol (DSPG) and 
distearoyl phosphatidylserine (DSPS) – negatively charged phospholipids, coupled 
with two cationic emulsifiers – namely brassicyl isoleucinate esylate (EM) and 
quaternary ammonium (QA). 
2.1. Selected physicochemical properties of liposomes 
In our experiments, most of the charge inducer agents (with only exception of QA), 
namely DSPG, DSPS and EM, – when incorporated into the liposomes – result in 
significant increase of the vesicle sizes as compared to neutral liposomes which 
have relatively smaller size (P < 0.05) as shown in Table 9. It was reported in some 
studies that this increase may be caused by an extraneous amount of these added 
inducers which increased the whole volume of lipid bilayer [1]. Moreover, 
considering the PDI value, our results showed that incorporated negative charge 
decreased the PDI value of the liposomes in comparison with unmodified neutral 
liposomes. This decrease represents a narrower vesicle size distribution and 
improves the homogeneity of formulation. Conversely, incorporated positive 
charge increased the PDI value of the liposomes resulting in lower homogeneity of 
vesicle size which however remains in the range of acceptable PDI values (≤ 0.3) 
[2]. 
In term of zeta potential, we observed L1 to possess a slightly negative charge 
and with almost no surface charge making it comparable to neutral liposomes [1, 
3]. L1_PS and L1_PG were observed to have a high negative charge on vesicle 
surface, while L1_EM and L1_QA possessed a high positive value surface charge 
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(Table 9). Moreover, the absolute values of the zeta potential of negatively – and 
positively – charged liposomes were in range above -/+ 30 mV for all charged 
liposomes, which indicates sufficient electrochemical stability for colloidal system 
[4]. 
Table 9 Physical characterizations of the different types of charged liposomes 
entrapping with 30mM CF in PBS (pH 7.4) *. 
Vesicle properties Zeta potential 
(mV) 
Deformability 
index (D) a 
%Entrapment 
efficiency (%EE) a 
Size (nm)a PDI 
167.1 0.30 54.17 11.09 49.29 
160.9 0.22 46.57 2.901 39.22 
112.2 0.19 -7.45 2.322 35.10 
44.63 0.15 -44.12 2.014 28.85 
30.21 0.05 -55.28 1.674 27.00 
a Values represent mean ±SD (n = 3) 
* Data including statistic in detail can be found in the Appendix A (II). 
Code 
Neutral 
liposomes 
Negatively charged 
liposomes 
Positively charged 
liposomes 
Lipid bilayer 
composition (%w/w) 
L1 L1_PG L1_PS L1_EM L1_QA 
Only PL90G 
(10) 
PL90G: 
DSPG (9:1) 
PL90G: 
DSPS (9:1) 
PL90G: 
EM (9:1) 
PL90G: QA 
(9:1) 
The essential characteristic of elastic/ flexible liposomes in comparison with 
classical liposomes and other type of colloidal systems is the flexibility of vesicle 
membrane – expressed in terms of deformability index (D) (Table 9) – under stress-
dependent adaptability [5]. It should be noted, however, that L1 – despite being 
composed of only PC – showed in our results the slight deformability. This might 
be explained that PC molecules has resulted in more flexible in lipid bilayer; reason 
being their structure which contain also unsaturated fatty acid chain, i.e. oleic acid 
(C18:1) that, by itself, can act as penetration enhancer [6]. This finding is consistent 
with Williams and Barry (2012) [7]. 
This indicates that vesicle flexibility depends upon the additives, both in case 
of negatively charged phospholipids and cationic emulsifiers. D-values were higher 
for liposomes with DSPG, DSPS and EM than that of neutral liposomes (L1). 
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2.2. Entrapment efficiency 
The assessment of capability to encapsulate for the liposomes was also investigated, 
in conjunction with CF (hydrophilic fluorescent dye) content in liposomal 
formulations. The entrapment efficiency (EE) was observed to be higher for both 
negatively charged liposomes (L1_PS and L1_PG) when compared to the neutral 
liposomes, while the positively charged liposomes (like L1_EM and L1_QA) 
showed lower relative drug entrapment. Being cationic emulsifiers, EM and QA 
markedly decreased the EE. Such behavior has been encountered in previous 
studies with one possible reasoning being that positive charged inducer agent 
induces a repulsion within the lipid bilayer possible [8] and another being 
interaction between positive charged inducer and lipid vesicles, thus destabilizing 
the packing characteristics and fluidizing properties of the lipid bilayer [9]. 
2.3. Ex vivo skin penetration study 
We realize that a simple agreement of physicochemical properties and entrapment 
efficiency does not comprehensively explain effects upon actual human skin. 
Therefore, we undertook studies examining penetration of CF through skin of 
negatively-, positively- and neutral charged liposomes are applied. All liposomal 
formulations were directly applied to human abdominal skin mounted in a vertical 
Franz’s diffusion cell. Penetration studies were carried out under non-occlusive 
conditions to allow the driving force provided by the osmotic gradient. The 
penetration profile is illustrated in Figure 13. We used CF in the same concentration 
of CF entrapped in liposomes as a reference sample. 
Upon 24 h incubation, small amount of CF (10%) from CF solution was 
observed to permeate into the receptor compartment with most of fluorescent dye 
remaining on the skin. However, this was not the case for all liposomal 
formulations. The high penetration efficiency of charged liposomes compared to 
solution of drug corroborates previous finding [10]. The cumulative amount of CF 
permeated in the positively-, negatively-, and neutral charged liposomes were 
significantly higher than in the CF solution (10%, P < 0.05), however we do not 
observe differences in cumulative amount of CF permeated between L1_PG, L1 
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and L1_QA (50.19, 45.61 and 44.11%, respectively). Such variations in CF release 
could be explained by variations in the headgroup of additive present in lipid bilayer 
effected by surface charge modifiers which has also been observed in previous 
studies [3, 11, 12]. 
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Figure 13 %Cumulative amount of CF permeated through full skin after 24 h. Applied with 
finite dose of 5 µl each liposomal formulation onto abdominal skin at 32C under non-occlusive 
condition of as function of time (h). 
Despite L1_EM showing the highest deformability index and being more 
flexible (as compared to the other formulations), it surprisingly does not exhibit a 
corresponding high CF penetration into the receptor fluid. In agreement, L1_EM 
showed a reduction in cumulative CF permeated after 24 h. We suspect that the 
positive headgroup of EM in L1_EM and some protein molecule within the skin 
layers cause a lowered CF release. In summary, penetration of substances through 
skin does not depend merely on specific liposome characteristics (e.g., small 
particle size, more flexibility) but also on the chemical structure of emulsifier 
incorporated into the lipid bilayer. Of equal and crucial importance, our results 
concerning the ex vivo penetration interestingly showed that, even though the 
L1_PG (negatively charged) can enhance the CF penetration through skin better 
than neutral liposomes (L1), L1_PS – containing also a negative charge – in contrast 
showed even worse penetrability than neutral liposomes. This finding – which has 
never been reported by any other researches in the field – could be the result of not 
only the surface charge affecting the penetrability, but also the reaction between 
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other additives incorporated into lipid bilayer and the phospholipids, resulting in 
the change of conformation in lipid bilayer and the penetration enhancement. 
2.4. Conclusion 
Not only does the surface charge of the liposomes play a dominant role for the 
interaction between vesicles and skin, it also contributes substantially to the drug 
penetration through deeper skin layers. We report that among the charged liposomal 
formulations tested in our experiments, only the negatively-charged liposomes 
formulated by using DSPG can enhance the CF permeation through the skin. 
Nonetheless, apart from the aforementioned discussion, a comprehensive and 
complete understanding of the intricate mechanism of this penetration event is still 
missing. We thus suggest that the incorporation of charged components (positive or 
negative) into lipid bilayer for enhanced skin penetration as illustrated by previous 
works [3, 12-17] is more complex an event than previously anticipated. In order to 
understand this point more accurately and in deeper detail, further specific and 
advanced experiments (e.g. Nuclear Magnetic Resonance (NMR)) focusing on the 
interaction between PC molecules and charged inducer agents in the lipid bilayer 
are needed. Furthermore, deformability index investigated in our studies is also not 
able to explain high penetration efficiencies convincingly suggesting the 
importance of factors other than lipid proportions governing this phenomenon. 
More importantly, our studies show that surface charge ascribable to emulsifiers 
does not govern penetration efficiencies, rather, the head group property (in term of 
chemistry) along with characteristics of drug being delivered can be decisive in 
determining penetration efficiency. There exists ipso facto a discrepancy between 
two groups of experiments as to how the different surface charge of liposomes 
affects the drug penetration through the skin. 
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3 Surface modification using polymer coating of liposomes 
Surface modifications of skin penetrable liposomes may have an effect on the 
enhancement of drug penetration through the skin. Here we evaluated one such 
method of enhancing drug delivery across skin by addition of polymer emulsifiers 
into the lipid bilayer. 
Such polymer additions to the lipid bilayer are expected to enhance the 
colloidal stability of conventional liposomal formulation for topical administration 
and markedly alter the physicochemical properties, especially drug penetrability. 
To this end, we measured this enhancement of liposomal function using two 
hydrophilic polymer groups – namely polyethyleneglycol (PEG) mono-ester and 
polyglycerol (PG) mono-ester. 
3.1. Polyethyleneglycol (PEG) mono-oleate group 
Information about PEGylated liposome for topical application is obscure in hitherto 
published literature. To the best of our knowledge only two studies reported 
PEGylated liposomes to have enhanced penetration of low molecular weight drug 
into deeper skin layers [1, 2]. Traditionally, DSPE-PEG has been used for such 
modifications which possess two fatty acid chains thus producing much larger 
particle size as compared to single fatty acid chain with a consequent rise in 
production costs. PEGylated liposomes considered here are comprised of 
unsaturated phosphatidylcholine derived from soy bean which is the main 
component and PEGx-mono-oleate (single chain surfactant), which provides the 
necessary physicochemical properties, especially deformability of these vesicles. 
This study demonstrates the influence upon penetration characteristics of 
liposomes due to incorporation of surfactants like PEG300-, PEG600-, PEG1000-, 
and PEG2000-monooleate. (Note: All preparations consist of 9% phospholipids, 
1% PEG-ester surfactant, 16% ethanol ad to 100% with CF solution or PBS by 
weight.) 
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3.1.1. Selected physicochemical properties of these liposomes 
A particle size analysis revealed that the size of all investigated vesicles was in the 
range of 44 nm to 96 nm (Table 10), which indicated that these vesicles were of 
acceptable size. (In principle, a small size is a highly desirable size since it enhances 
penetration into the skin [3].) However, we noted that the mean particle size of 
PEGylated liposomes was greater than non-PEGylated liposomes due to an increase 
in bilayer surface hydrophilicity caused mainly by incorporation of PEG-esters. The 
polydispersity index (PDI) values of all investigated vesicles range from 0.09 to 
0.30. Moreover, all PEGylated liposomal formulations had PDI values well below 
0.20 as compared to non-PEGylated liposomes a phenomenon not reported in 
previous studies [4] which tested variations of PEG2000: DSPE ratio in the 
investigated liposomal preparations. These vesicles were of uniform size which as 
a factor was independent of the quantity of PEG2000-DSPE incorporated. 
Table 10 Characterization of different liposomes (Data with standard deviation are 
presented in Appendix A (III)). 
Rank 
Vesicle properties 
Zeta potential 
(mV) 
Deformability 
index 
% Entrapment 
efficiency(%EE) 
Size (nm) PDI 
1 95.31 0.30 -7.45 3.67 41.09 
2 89.24 0.20 -9.58 2.03 39.55 
3 64.23 0.15 -11.77 2.01 37.67 
4 60.14 0.14 -12.58 1.07 37.30 
5 44.60 0.09 -12.63 0.93 35.10 
 
Code L1 L1_PEG300 L1_PEG600 L1_PEG1000 L1_PEG2000 
Lipid bilayer 
composition 
(%w/w) 
PL90G 
(10) 
PL90G:PEG300 
(9:1) 
PL90G:PEG600 
(9:1) 
PL90G:PEG1000 
(9:1) 
PL90G:PEG2000 
(9:1) 
Both vesicular stability and skin-vesicle interactions are also functions of zeta 
potential, which describes the surface charge. Specifically, the absolute values of 
the zeta potential for negatively - and positively - charged liposomes should be in 
the range above -/+ 30 mV respectively for sustaining colloidal stability [5]. The 
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mean surface potential of PEGylated liposomes differs by -7.45 mV as compared 
to non-PEGylated vesicles and by -12.63 mV for PEG300-modified vesicles. This 
incorporation of PEG-monooleate into lipid bilayer though slightly affects the total 
surface charge of liposomes. 
Further parameter, the capacity to pass through the skin barrier is dependent 
on the vesicle bilayer fluidity, reported as D value). Table 10 shows a strong impact 
of PEG-monooleate addition on the deformability index, which in turn was related 
to the chain length of the polymer. L1_PEG300 formulation exhibited a markedly 
higher deformability index followed by unmodified liposomes (L1) and 
L1_PEG600. Furthermore, low deformability was observed in long PEG-chain 
modified liposomes; L1_PEG1000and L1_PEG2000. A short PEG-chain molecule 
(PEG300) embedded into the bilayer can increase the fluidity of the vesicle 
membrane (addition of edge activators) than a longer PEG-chain due to increases 
steric hindrance and shows a lower penetration. 
Increased drug entrapment efficiency in carrier vesicles can achieve a 
stronger therapeutic effect at the target site.  As shown in Table 10, there were no 
significant differences in the entrapment efficiency (EE) between L1_PEG300 and 
L1_PEG2000. The highest EE of CF was determined in L1_PEG600 with 41.09%, 
which was higher than that in non-PEGylated ones. 
3.1.2. Stability studies 
We also investigated the stability of liposomes in terms of mean particle size and 
entrapment efficiency after storage for 3 months at room temperature. The two 
PEGylated liposomal formulations composed of short chain PEG (L1_PEG300 and 
L1_PEG600) maintained their vesicles sizes at low PDI value (PDI < 0.20) in 
contrast to the L1_PEG1000 and L1_PEG2000 liposomes (Figure 14(A)). 
However, in non-PEGylated liposomes, a strong increase in average particle size 
was observed which was accompanied by a high heterogeneity of the vesicles (PDI 
>> 0.30). This can be caused by aggregation, which results in a close proximity of 
vesicles surfaces and can result in fusion of liposome membrane, due to instability 
of the bilayer [6]. 
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Figure 14(B) shows the liposomal stability in term of percentage of retained 
encapsulated CF which was only observed with L1_PEG300, while other 
formulations showed a decrease in CF entrapment over the time period of 3 months. 
We observe a marked increase of % CF leakage in L1_PEG1000, which could not 
be explained. 
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Figure 14 Colloidal stability of liposomes upon storage at room temperature. (A) The average 
size of the liposomes for 0 (   ), 1 (   ), 2 (   ), and 3 months (   ). (B) The percentage of 
carboxyfluorescein of liposomes over a period of 3 months. 
3.1.3. Ex vivo skin permeation study 
The permeation enhancing effect for hydrophilic substances could be higher 
importance than in case of lipophilic drugs, due to relatively lower permeation of 
hydrophilic molecules and hence needing more enhancement [7, 8]. Several studies 
suggest a possible permeation enhancing mechanism for surfactant- based elastic 
vesicles [9]  and different kinds of deformable liposomes [10- 15] .  Therefore, we 
investigated whether the modification of the liposomal surface with different PEG 
molecules has an impact on the permeation of CF through the skin. 
Figure 15 shows ex vivo skin permeation profiles conducted with different 
formulations of CF.  Two references were used:  a solution of CF and PL90G 
liposomes loaded with CF (CF-PL90G). Cumulative CF amount that permeated the 
skin in a time period of 24 h after non- occlusive application was highest for CF-
PL90G: PEG300 liposomes ( 49.63 ± 1.26% ) , followed by the pure CF- PL90G 
liposomes (39.45 ± 2.01%), CF-PL90G:PEG600 liposomes (38.53 ± 1.91%) and at 
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the end CF-PL90G:PEG1000 liposomes (27.33 ± 1.88%) and CF-PL90G:PEG2000 
liposomes (24.36 ± 1.34%), respectively. 
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Figure 15 Percentage of carboxyfluorescein permeated from liposomes encapsulating 
carboxyfluorescein as a function of time. All values represent as mean ± SD (n=3). 
3.1.4. Ex vivo and in vivo tape stripping study 
Figure16 shows the amount of CF determined upon strips 1st, 5th, 10th and 15th. The 
other strips were not considered in order to maintain a feasible sample number (data 
not shown). The result showed that the amount of CF decreases with the number of 
strips taken from skin. As shown in Figure 16, for the first strip, we observed a 
high difference in CF content between the CF solution and the PL90G:PEG300 
liposomes. We see that PL90G:PEG300 liposomes was the best formulation when 
compared to the other formulations. Trebilcock et al. (1994) studied the correlation 
between in vitro and in vivo tape stripping method and observed the penetrant 
amount reduced gradually with increasing depth in both in vivo and in vitro 
situations, with enhanced rapidity for the first five strips [16]. The observation of 
this gradient was a result of the reduced structural integrity of the stratum corneum 
near the skin surface, hence more skin is removed in the first few strips. The amount 
of CF deposited in human skin strip 15th (see enlargement in Figure 16) consistently 
high for in vitro skin penetration studies at 24h. (Note: A good correlation could be 
shown between the CF amount in strip 15 and % CF released in 24h.). 
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Figure 16 Amount of carboxyfluorescein as a function of the strip number (µg/cm2). CF sol: 
solution of carboxyfluorescein in mixture solvent (ethanol: PBS, pH7.4) and CF-PL90G: PL90G 
liposomes loaded with carboxyfluorescein (without PEG surfactant) (n=3). 
The biological variation of the human skin resulted in large standard 
deviations and therefore we incorporated replicates in the experimental design 
(n=3). The ex vivo penetration study used PEG surfactants incorporated into to 
measure influence on skin permeation. Moreover, the chain length (300 to 2000) of 
PEG molecules embedded in lipid bilayer influenced particle size, deformability, 
and showed a decreased CF permeation through skin. An increased permeation of 
CF from PL90G:PEG300 liposomes, compared with non-PEGylated liposomes, 
were in accordance with the study by Jain et al. [1], which reported an increased 
drug permeation across rat skin by PEGylated liposomes. In this investigation, the 
amount of CF permeated from PL90G:PEG2000 liposomes was similar to CF-
PL90G liposomes in both in vitro Franz diffusion study and ex vivo tape stripping 
study. There were no differences between the profiles measured by both studies. 
This might be resulting from decreased permeation of CF through the skin. Even 
though the mean diameter of PL90G:PEG2000 liposomes is about 95.31 nm 
(approximate to PL90G:PEG300 liposomes, 89.24 nm), PL90G:PEG2000 
liposomes did not easily pass through the skin. This may be due to their ability to 
draw water into molecules of PEG chain, forming a water boundary around the 
vesicles. Furthermore, the skin permeation results were consistent with the 
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deformability studies (as shown in Table 10), showing a low deformability value 
(D = 0.93) as compared with CF-PL90G liposomes (as control). 
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Figure 17 Tape stripping permeation study of carboxyfluorescein, ex vivo – in vivo 
correlation. A: Tape stripping study of CF-solution, B: Tape stripping study of PL90G, C: Tape 
stripping study of PL90G:PEG300, D: Tape stripping study of PL90G:PEG600 and E: Tape 
stripping study of PL90G:PEG2000, respectively. 
Skin tape stripping results obtained ex vivo and in vivo with CF in mixture 
solvent were also compared in Figure 17. They showed a correlation of permeation 
between excised human skin (ex vivo) and human skin (in vivo) studies in these 
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liposomal formulations. Concerning the amount of CF permeated through the skin, 
in vivo tape stripping systematically showed a higher CF amount skin of penetration 
than ex vivo tape stripping study. 
According to the results, an increase in polyethyleneglycol ( PEG)  chain 
length decreased the amount of CF permeated through human skin.  These 
observations are in agreement with the results, obtained by deformability studies as 
shown in Table 10. To verify the independence of deformability behavior from the 
molar ratio of phospholipid to PEG- ester is 1:  0.147 in case of PL90G: PEG300 
liposomes and only 1: 0.038 in case of PL90G:PEG2000 liposomes, we examined 
variations in ratios of PL90G and PEG-esters for deformability. 
Table 11 Effect of PEG concentration in liposomal formulations on physical 
properties of PEGylated liposomes. 
Formulation Code 
Molar 
ratio 
Particle size 
(nm) 
PDI 
Deformability  
index (D) 
PL90G:PEG300 a 1 : 0.038 85.65 ± 1.20 0.10 ± 0.09 1.95 ± 0.32 
PL90G:PEG300 a 1 : 0.147 89.24 ± 1.21 0.14 ± 0.01 3.67 ± 0.03 
PL90G:PEG2000b 1 : 0.038 95.31 ± 0.84 0.15 ± 0.11 0.93 ± 0.20 
PL90G:PEG2000b 1 : 0.147 91.63 ± 0.44 0.20 ± 0.07 0.66 ± 0.18 
Values represent mean ± S.D. (n = 3) 
a PL90G liposomes composed of PEG300 
b PL90G liposomes composed of PEG2000 
As shown in Table 11, an increase in the molar ratio of PEG-ester surfactant 
into phospholipid bilayer did not change the size of vesicles. Increasing the amount 
of the short PEG- chain ester into the vesicle bilayer rather led to an improvement 
in the deformability index which represents the penetration capability through the 
skin.  This single chain emulsifier with only PEG 6 units may act as edge activator 
increasing the flexibility of the vesicles thus improving their ability to squeeze 
through artificial membranes with pore size ½ of vesicle size. Van den Bergh et al. 
[9]  also described this phenomenon with an increased addition of PEG- 8- laurate 
into vesicles formed by sucrose laurate with a concordant improvement in elasticity 
values achieved.  In contrast to these findings, the PEG 2000 liposomes with the 
higher ratio in the polymer content exhibited less deformability. That can be due to 
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more pronounced steric hindrance at the particle surface increased by the 
immobility of the PEG chains. 
Polymer- grafted lipid membranes ( PEG2000- DSPE/  PEG5000- DSPE) 
showed a distinct molecular interaction at the lipid bilayer surface compared to non-
modified ones [ 2] .  The thickness of simple phospholipid/ water interface is 
approximately dp ~ 1 nm and rises to 5- 10 nm when long- chain PEG- molecules 
were embedded in the membrane [ 10, 17] .  A possible explanation for the 
differences in drug skin permeation of polymer-grafted liposomes is the difference 
in surface polarity combined with the steric hindrance on the particle surface. Cevc 
and Blume ( 1992)  [10, 17]  reported that transfersomes can penetrate through the 
skin owing to the transdermal osmotic gradients and hydration force. If the osmotic 
gradient is lowered by strong hydration on the vesicle surface due to the 
incorporation of long- chain PEG- esters, the permeation of PEG1000/  PEG2000 
liposomes can also be diminished.  There seems to be an exclusion size in the 
molecular weight of the PEG- esters:  MW ~ 300 showed penetration enhancing 
effects and MW > 1000 suppressed the ability of penetration. An interesting factor 
might be the addition of selected PEG- ester being able to trigger the penetration 
depth as well as the kinetic of modified liposomes. 
3.2. Polyglycerol (PG) mono-oleate group 
Why we selected the group of polyglycerol (PG) emulsifiers for incorporating into 
lipid bilayer of liposomes? This study compares various polymer emulsifiers to find 
an alternative to PEG emulsifier embedding into lipid bilayer of liposomes for 
cosmetic production. However polymers – e.g., poly(glycerol-derived polymers 
[18], polyvinyl pyrollidone [19], and polyvinyl alcohol [20] – have been approved 
to be alternatives to PEG in preparing long circulating liposomes [21] for 
pharmaceutical purposes. 
Therefore, the main purpose of this study was to modify the surface of 
liposomes using PG for improving hydrophilic fluorescent dye through skin using 
ex vivo skin penetration. The effect of observed differences of polyglyceryl chain 
length in lipid bilayer on physicochemical properties and skin permeation profiles 
were examined. 
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3.2.1. Physicochemical properties of liposomes 
The current study demonstrated that it is possible to influence the penetration of 
liposomes by surfactants like PGMO4 (MW 500), PGMO5 (MW 575), and 
PGMO10 (MW 947). As shown in Table 12, particle sizes of all investigated 
vesicles were in the range of 29 nm to 51 nm, indicating that vesicles were of a 
small size. This is a highly desirable attribute for the ability of penetration into the 
skin. Clearly, when increasing the polyglyceryl group from 4 to 10, a decrease in 
mean diameter of vesicles was detected. 
The polydispersity index (PDI) of the investigated vesicles had values from 
0.13 to 0.30. Moreover, all PGMO liposomal formulations were homogenously 
with low PDI values well below 0.30, as compared to conventional liposomes. 
Table 12 Characterization of different liposomes (Data with standard deviation 
are presented in Appendix A (III)). 
Rank 
Vesicle properties 
Zeta potential 
(mV) e 
Deformability 
index (D) 
%Entrapment 
efficiency(%EE) e 
Size (nm)e PDI e 
1 50.32 0.30 -4.81 2.40 40.21 
2 44.60 0.25 -7.45 2.01 38.44 
3 35.07 0.18 -7.99 1.85 35.10 
4 29.12 0.13 -14.1 1.70 32.48 
 
Code L1 L1_PGMO4 L1_ PGMO5 L1_ PGMO10 
Lipid bilayer 
composition 
(%w/w) 
Only 
PL90G (10) 
PL90G:PGMO4 
(9:1) 
PL90G:PGMO5 
(9:1) 
PL90G:PGMO10 
(9:1) 
The zeta potential is related to the charge on the surface of the vesicle which 
may influence both vesicular properties such as stability, as well as skin-vesicle 
interactions. The result show that a high negative charge on L1_PGMO10 whereas 
L1_PGMO4 and L1_PGMO5 show decrease negative charge which also follows 
the trends of polyglyceryl group (Table 12). 
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Several reports in dermal drug delivery pointed out the capability of vesicles 
passing through the skin barrier is dependent of the vesicle bilayer fluidity. As 
shown in Table 12, the addition of PG-mono-oleate had an effect on the 
deformability index depending on the chain length of the polymer. One formulation, 
CF-PL90G:PGMO4 exhibited a significantly higher deformability index, followed 
by CF-PL90G:PGMO5 and CF-PL90G:PGMO10, respectively. It might be 
explained that short PG chain molecule (PGMO4) embedded into the bilayer can 
increase the fluidity of the vesicle membrane (addition of edge activators), and as 
longer the PG-mono-oleate chain is as more steric hindrance will arise and lowers 
the penetration. 
Drug entrapment efficiency in carrier vesicles can achieve a stronger 
therapeutic effect at the target site. As shown in Table 12, there were no significant 
differences in the entrapment efficiency (EE) between the formulations. 
3.2.2. Stability studies 
After 3 months of storage at room temperature with light protection, the two PG-
mono-oleate liposomal formulations composed of short chain PG (CF-
PL90G:PGMO4 and CF-PL90G: PGMO5) still retained their vesicles sizes at low 
PDI value (PDI < 0.20) in contrast to the CF-PL90G:PGMO10 liposomes (as shown 
in Figure 18). 
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Figure 18 Colloidal stability of liposomes upon storage at room temperature. The average 
size of the liposomes for 0 (   ), 1 (   ), 2 (   ), and 3 months (   ). 
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CF-PL90:PGMO10 liposomes had slightly increasing in particle size after 
storage for 3 months. In part of CF-PL90G, a strong increase in average particle 
size was observed accompanied by high heterogeneity of the vesicles (PDI >> 
0.30). This can be the result of aggregation, resulting in a close apposite of vesicles 
surface and fusion of liposome membrane, relating to instability bilayer [6]. 
3.2.3. Ex vivo skin permeation study 
Penetration through skin for hydrophilic substances is subject to greater inhibition 
as compared to hydrophobic substances. Hence, this characteristic seems to be more 
important especially in case of lipophilic drugs, since permeation of hydrophilic 
molecules tends to be relatively lower and hence can be subjected to further 
enhancement [7, 8]. 
Several studies suggested a possible permeation enhancing mechanism for 
surfactant-based elastic vesicles [9] and different kinds of deformable liposomes 
[10-15]. Therefore, it was investigated whether the modification of the liposomal 
surface with different PG molecules has an impact on the permeation of CF through 
the skin. 
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Figure 18 Percentage of carboxyfluorescein permeated from liposomes encapsulating 
carboxyfluorescein as a function of time. All values represent as mean ± SD (n=3). 
Results obtained from ex vivo skin permeation profiles conducted with 
different formulations of CF are shown in Figure 18. Two references were used: 
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solution of CF in ethanol: PBS (50: 50 w/w) (CF solution) and PL90 liposomes 
loaded with CF (CF-PL90G). Cumulative CF amount that permeated the skin in a 
time period of 24 h after non-occlusive application was highest for CF-PL90G: 
PGMO4 liposomes (46.57 ± 4.36%), followed by CF-PL90G: PGMO5 liposomes 
(36.43 ± 8.44%) and at the end CF-PL90G: PGMO10 liposomes (25.06 ± 6.84%) 
respectively. 
3.3 Conclusion 
We observe that incorporation of PEG ester surfactants like PEG300-oleate into 
lipid bilayer alters the liposome physicochemical properties. This is manifested as, 
larger particle diameter, low PDI values, increased deformability, even slightly 
higher entrapment efficiency and better physical stability over a time period of 3 
months at room temperature. Moreover, ex vivo skin permeation studies revealed 
that short chain length PEG embedded in the lipid bilayer of vesicles enhances the 
transdermal activities of the hydrophilic fluorescent substance, CF. However, the 
quantity of CF penetrating into the skin is decreased by modification of liposomes 
with long-chain PEG-esters like PEG1000-oleate or PEG2000-oleate as compared 
to short chain PEG esters.. In conclusion, modifying liposomes with PEG-esters 
affect the physicochemical properties as well as the penetration depth of these 
vesicles which strongly depends on the chain length of the used PEG-esters. 
The incorporation of PG-mono-oleate surfactant molecules with short chain 
length, especially PGMO4 surfactant, into lipid bilayer produces smaller and more 
stable liposomes. The elasticity of lipid bilayers appears to be of greater importance 
in the enhanced skin delivery of CF by PGMO liposomes, under non – occlusive 
conditions. Modifying liposomes with PG-mono-oleate not only affects the 
physicochemical properties but also the penetration depth of these vesicles which 
is strongly dependent on the chain length of the used PG-mono-oleate. In 
comparison, the results of PL90G: PGMO4 and PL90G: PG (L1_PG; in Chapter 
2), they showed that PL90G: PGMO4 had a smaller size than PL90G: PG (160.9 
nm) and a less negatively charged on liposomes surface. Not only were the observed 
elasticity of PL90G: PGMO4 and PL90G: PG similar, but also their CF permeation 
into the skin were also enhanced. 
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In case of PEG-esters and PG-esters when embedded into lipid bilayer of 
liposomes, resulted in short chain hydrophilic of PEG (PEG300) and PG (PGMO4) 
having good characteristics with subsequent enhancement of skin permeation. 
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4. Sugar-derivatives: Emulsifier effects onto the lipid bilayer of 
liposomes for membrane fluidization improvement 
Besides polymer esters, sugar derivatives can also behave as an emulsifier with 
capacities to enhance the skin penetration capability of conventional liposomes. As 
a result, we investigated the following sugar derivatives as a class of penetration 
enhancer – namely sucrose oleate (SO), cetearyl glycoside (CG), and polyglyceryl-
3 methylglucose distearate (TE) – which behave as emulsifiers during formulation 
and are commonly used in the pharmaceutical industry. This class of molecules 
generally act by altering the ordered structure of the intercellular region of the 
stratum corneum [1-3] and allow the active ingredient to pass through stratum 
corneum to deeper skin layers. Furthermore, we observe that these three penetration 
enhancers show a hydrophilic-lipophilic balance (HLB) value in the range of 10-15 
which suggest a balanced hydrophilic–lyophilic nature with possible controls on 
the size of the liposomes. These derivatives existed in liposomes in hydrophilic-
lipophilic balance (HLB; Table 12) or as mixed surfactant system so as to enhance 
ease of incorporation into lipid bilayer of liposomes. 
4.1. Selected physicochemical characteristics of liposomes 
As shown in Table 13, all of the sugar derivatives – when incorporated into 
lipid bilayer of liposomes – resulted in a significant increase of the vesicle sizes as 
compared to conventional liposomes (L1) which had smaller size (P < 0.05). Such 
increase in size may be due to the incorporation of sugar ester molecules into the 
lipid bilayer and the disordering and destabilization of lipid bilayer [4, 5]. 
Especially after considering the increasing of vesicle size in the following order 
L1_SO > L1_TE > L1_CG we found an interesting observation that the increased 
size of modified liposomes varied inversely with the HLB value of sugar esters. 
However, this observation requires further prove for being capable of explaining 
the relation between the vesicle size and the HLB value. PDI values of all tested 
modified liposomes were in an acceptable range (PDI < 0.30) [6]. 
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Table 12 Chemical Structure, HLB and overall shape value of sugar ester 
derivatives. 
Chemical 
name 
Cetearyl Glucoside 
(CG) 
Sucrose oleate (SO) 
Polyglycerol-3-
methylglucose 
distearate (TE) 
Polar 
headgroup 
 
Hydrophobic 
tail 
 
  
HLB 11 15 12 
Overall shape    
Table 13 Physical characterization of the different types of liposomes with 
sugar derivatives (Data with standard deviation are presented in Appendix A (II)). 
Vesicle properties 
Zeta potential 
(mV) 
Deformability index 
(D) 
%Entrapment 
efficiency (%EE) 
Size (nm) PDI  
119.3 0.29 5.87 3.297 58.44 
72.98 0.25 -7.45 3.253 54.26 
67.76 0.19 -13.57 3.192 49.95 
44.60 0.17 -35.47 2.014 35.10 
 
Code L1 L1_SO L1_CG L1_TE 
Lipid 
composition 
(%w/w) 
Only PL90G 
(10) 
PL90G:SO (9:1) PL90G:CG (9:1) PL90G:TE (9:1) 
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Zeta potentials of the liposomes indicate a slight positive charge on SO 
liposome whereas CG and TE show increased negative charge which also follows 
the trends of complexity caused by the sugar structure (Table 13). The liposomes 
despite affected packing structure were found to be significantly more flexible (in 
terms of D values from Table 13, P < 0.05) compared to conventional liposomes 
without sugar derivatives. A possible explanation for such improved flexibility 
could be the disruption of ordered lipid bilayer structure by sugar derivatives 
incorporation. 
4.2. Entrapment efficiency 
Liposomes are often synthesized and selected for enhanced entrapment efficiency. 
Entrapment efficiency is not only dependent on bilayer permeability, stability and 
drug complexation in liposome but also upon component stoichiometry of the 
bilayer. The entrapment efficiency (Table 13) of all three modified liposomes were 
significant higher as compared to unmodified liposomes (L1) (P < 0.05). The sugar 
molecules in lipid bilayer could assist an increase of volume capacity of the inner 
core of liposomes also influencing entrapping hydrophilic compound. 
4.3. Ex vivo drug penetration studies 
Despite possessing favorable physicochemical characteristics, the true measure of 
liposome performance is its penetration into abdominal skin as investigated here 
using an ex vivo skin penetration study (as illustrated in Figure 20). 
The release of CF as a function of time was observed to be enhanced in all 
our formulation with SO and CG showed a 4 and 3.8 times increased enhancement 
respectively when compared to aqueous CF. However only L1_SO was observed 
to have and enhancement in excess of the conventional liposome into skin. This 
result may be due to unsaturated fatty acid chain (C18:1) and large polar headgroup 
of the SO molecule. The release rate decreased as follows: L1_SO > L1_CG > L1 
> L1_TE. At first point 2 h, we observed that L1_SO and L1_CG had a higher 
release CF as compared to L1_TE. 
71 
 
 
Figure 20 Skin permeation of CF after 24 h non-occlusive application of different CF 
formulations onto human abdominal skin (expressed as % cumulative of dose released ± S.D., n = 
3) 
Interestingly, we observe a sustained release over 4-6 h for L1_CG followed 
by a sudden release after 24 h. This could be explained by a sudden loss of 
membrane integrity due to small headgroup size of CG and saturated fatty acid 
chain. TE exhibited a prolonged release function into the receptor compartment 
which may be due to a large head group accompanied by two saturated fatty acid 
chain (C18:0) overall retaining a cylindrical shape, causing a denser lipid packing 
which could cause a controlled drug release. 
4.4. Conclusion 
Non-ionic surfactants have been clearly shown to influence percutaneous 
absorption rate of drugs i.e., lidocaine, ibuprofen [7-9]. Different functional groups, 
hydrocarbon chain length and degree and position of unsaturation can impact the 
efficacy of penetration enhancers. Sugar fatty acids – non-ionic surfactants – can 
alter membrane barrier properties temporarily [10-12]. We emphasize that 
incorporation of sugar esters into lipid bilayers can improve the flexibility of bilayer 
and enhance skin penetration profile, ultimately enhancing drug delivery into the 
skin. Sugar ester derivatives are due to their detergent-like structure able to 
influence liposome physicochemical properties in turn manipulating its penetration 
through human skin, specifically, we observe L1_SO to be the best formulation. 
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We suggest to consider the incorporation of sugar derivatives. The sugar ester 
structure should possess a large headgroup and long chain fatty acid for improving 
the membrane elasticity and enhancing the skin penetration of drug. 
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Summary 
Liposomes are an important component of modern drug delivery strategies. There 
is increasing interest of late in using them as preferred drug carrier systems for 
topical application. In the past decades, conventional liposomes obtained by 
incorporation of phospholipids (e.g., hydrogenated soya phosphatidylcholine and 
dipalmitoylphosphatidylcholine; DPPC) and cholesterol in the lipid bilayer do not 
penetrate efficiently across the skin, confining them to the upper layers of the 
stratum corneum. In order to overcome the obstacle of drug penetration through the 
biological barrier, the next generations of deformable liposomes – namely 
Transfersomes®, ethosomes and invasomes – exhibit high skin penetration 
efficiency, greater control on drug delivery and improved drug solubility and 
stability, was developed by Cevc (1996), Touitou et al. (2000) and Dragicevic-curic 
et al. (2008) respectively [1-3]. The lipid bilayer of these deformable liposomes was 
composed of unsaturated phospholipids and penetration enhancer – e.g., sodium 
cholate, nonionic surfactants (Tween80®, Span80®, etc.), terpenes – which 
destabilizes the bilayer structure and generates the elasticity of lipid bilayer. 
Hitherto, among the characteristics of liposome, e.g. particle size, surface charge, 
flexibility of lipid bilayer, it was – and still is – not completely clear which 
characteristic or characteristics should be more intensively considered in order to 
improve the drug penetration enhancement, and what should be the ideal 
characteristic of surfactant (which serves as our interested group of penetration 
enhancer in this study). In the light of aforementioned characteristics, we 
anticipated that the surface modification of liposomes using different surfactants 
will yield the different penetration capability and therefore provide us a guideline 
as to which substances should be incorporated into the lipid bilayer in order to 
improve the penetration enhancement. 
Thus, in order to investigate influences of emulsifiers we selected a model 
liposome with a native surface having no emulsifiers having a z-potential of – 7mV, 
which is representative for uncharged phospholipid bilayer membranes. Gillet et al. 
(2011) have observed that a net negative native surface charge in phospholipid 
liposomes exhibit high penetration efficiency [4], however, Manosroi et al. (2004) 
have suggested the same for positively charged liposomes [5]. This net native 
75 
 
charge of the liposomes due to the phospholipid composition interferes with 
attributing and measuring effects brought about by emulsifiers as they too can also 
alter surface charge. Membrane elasticity too can alter effectiveness of liposomes 
to perform upon skin. Here we measured the deformability index (D) for our 
liposomes and expect better skin penetration efficiency (due to enhanced flexibility) 
for liposome preparation possessing high D value. Hence, based on these 
characteristics an ideal model liposome for surface modifications should exhibit 
little or no surface charge, have a high deformability index and be of small size. We 
investigated five commercial phospholipids liposome models (PL90G, NAT8539, 
LPC20, SUN70P and SUN90P) and selected PL90G (> 95% unsaturated PC) as a 
candidate for surface modifications as it possessed lower negative charge compared 
to NAT8539 and LPC20, exhibited higher D values compared to SUN70P and 
SUN90P. 
Charged phospholipids like distearoylphosphatidylglycerol (DSPG) and 
distearoylphosphatidylserine (DSPS) yielded liposomes with a negative charge 
whereas quaternary ammonium (QA) and brassicyl isoleucinate esylate (EM) 
incorporation resulted in liposomes with net positive charge. Slightly negative 
PL90G liposomes were used as control liposomes to compare these production 
iterations. Biological performance of these liposomes was tested using multiple ex 
vivo skin based assay methods. Tape stripping to human skin and collection of 
penetrating liposomes (Franz’s cell experiment) underneath the investigated skin 
revealed effective penetration of both positive and negative liposomes. Positively 
charged QA containing liposomes have higher penetration compared to EM 
containing liposomes and were similar to PL90G liposomes in this regard. In 
agreement with Gillet et al. (2011) finding [4], we also observed negative DSPG 
containing liposomes exhibited a high penetration efficiency when compared to 
DSPS and control PL90G liposomes. As we used neutral liposomal preparation for 
these surface changes we can report that this penetration enhancement can be only 
due to the use of DSPG (negatively charged headgroup modifier phospholipid) for 
better penetrability. 
Since headgroup modifications were observed to exert effect on penetration 
characteristics we further hypothesized that the size of a modified hydrophilic 
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headgroup can affect performance of the liposomes. Polymeric surfactant 
molecules like Polyethyleneglycol (PEG) monooleate and Polyglycerol (PG) 
monooleate containing varying polymer chain length were used for production of 
liposomes. Compared to control PL90G liposomes these emulsifiers increased 
headgroup size producing liposomes with larger vesicle size. In agreement with 
previous study, we too observed that such headgroup size changes do enhance 
liposome shelf life at room temperature. Increase in polymeric chain length of 
headgroups caused a concurrent increase in vesicle size, however, this size increase 
was not able to enhance penetration efficiency of the liposomes. It must be noted 
that incorporation of emulsifier having smaller headgroup is able to enhance 
simultaneously both membrane elasticity and skin penetration properties, however, 
at higher headgroup size though there is no enhancement of skin penetration. The 
smallest polymer size in both PEG monooleate (PEG300) and PG monooleate 
(PGMO4) firstly enhanced deformability index values and % entrapment efficiency 
of the modified liposomes as compared to PL90G liposomes control and secondly, 
compared to their larger counterparts demonstrated higher penetration efficiency. 
Molecular weight (MW) of hydrophilic headgroup and emulsifier type plays a 
significant role in determining activity and in our case, we see that smallest PEG300 
(MW 300) headgroup is much more potent than PGMO4 (MW 500) headgroup 
in penetrating skin and may be due to enhanced steric effects which directly affects 
the hydrophilic headgroup of the phospholipids enhancing liposome characteristics. 
We also reported here that incorporation of small polymeric headgroup (in our case, 
PEG300 and PGMO4) of liposomes are strongly associated with its ability to 
penetrate skin as revealed by ex vivo studies. 
Headgroup modifications can also have profound effects on well-organized 
packing arrangements of lipid bilayer in liposomes. Membrane flexibility of vesicle 
is known to allow liposomes easier access to stratum corneum. Non-ionic 
surfactants like sugar derivatives can alter the liposome bilayer packing as a result 
affect the deformability index thus increasing liposome flexibility [6]. This study 
uses three sugar derivatives namely sucrose oleate, cetearyl glucoside and 
polyglyceryl-3 methylglucose distearate to assess changes in membrane packing. 
All three substances were observed to bring about skin penetration enhancement. 
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Sucrose oleate and cetearyl glucoside have very similar time dependent functions 
for skin penetration. These findings suggest that structural complexity of the 
headgroup molecule constrain the penetration enhancement effect. As compared, 
the complex molecule of polyglyceryl-3 methylglucose distearate was observed for 
less penetration through skin. Despite structural similarity between sucrose oleate 
and cetearyl glucoside (that is, both have one small hydrophilic head group and one 
hydrophobic tail), the former achieved in our experiment the highest penetration 
efficiency which could be – according to our construal – attributed to its differed 
conformation composing of C18:1 unsaturated fatty acid chain (in comparison with 
the latter composing of C18:0 saturated fatty acid chain), which makes the packing 
of lipid bilayer of sucrose oleate looser and more flexible. 
Modification of liposomes by changes to the headgroup layer is a powerful 
tool for enhancing properties of the liposome itself. However, a potentially more 
powerful approach is to modify the skin’s barrier resistance reversibly thus enabling 
the stratum corneum to be more susceptible to the liposomes. This is achieved 
through agents which can either disrupt the molecular arrangement of lipids 
enabling formation of penetration channel paths or use the existent pores on the 
stratum corneum to enable entry and drug delivery. Though a number of such 
compounds exist which can alter skin characteristics, in this study, we evaluated 
application of three, namely, highly lipophilic compounds like a terpene mixture, a 
non-ionic surfactant like tween 80 and phospholipids to impact skin barrier 
functions and enhance penetration. These compounds are broadly grouped as 
penetration enhancers [7, 8]. A number of liposome types were produced by us 
namely transfersomes (using tween80) [9], invasomes (using terpene mixtures) 
[3][7] and phospholipids liposomes and were compared with conventional 
liposomes (produced by emulsifying neutral lipids with cholesterol). Enhanced 
penetration properties are complex factors often depending on many aspects of the 
liposomes. We observe invasomes penetrate skin better than transfersomes whereas 
conventional liposomes are unable to penetrate skin effectively suggesting terpene 
mixture treated liposomes possess better membrane elasticity and penetration 
enhancement properties. 
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Concluding remarks 
Neutral liposomes like PL90G are an ideal model liposome to evaluate effects of 
surface modifiers with potential to enhance liposome performance. This study also 
reports that surface charge of liposome, when modified by emulsifiers (especially 
negatively charged donors being used in our experiment: DSPG), can also enhance 
biological performance of the liposome compared to unmodified liposomes. 
Polymeric headgroup of PEG300 and PGMO4 (MW 300 and 500, respectively) 
enhanced liposomes can penetrate the stratum corneum efficiently, however, the 
performance gain is restricted to a certain size and does not apply across the entire 
possible size range. Sucrose oleate incorporated liposomes are observed to perform 
better than other sugar derivatives by synergistically modifying both the liposome 
bilayer characteristics and altering stratum corneum to enhance access. Similarly, 
penetration agents altering skin barrier characteristics too perform better than 
conventional liposomes. In the light of these findings we are also able to suggest a 
four level index based on CF permeation assays (Figure 21) based on the fact and 
discussion above. 
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Figure 21 Comparison of cumulative amount CF permeated through the skin at 24h of all liposomal 
formulations based on PL90G-based liposomes (L1_PG: PL90G liposomes containing DSPG, L1_PEG300: 
PL90G liposomes containing PEG300-monooleate, L1_TP: PL90G liposomes containing terpene mixture, 
L1_PGMO4: PL90G liposomes containing PG4-monooleate, L1: PL90G liposomes without no additives, 
L1_TW: PL90G liposomes containing tween80, L1_QA: PL90G liposomes containing quarternary ammonium, 
L1_SO: PL90G liposomes containing sucrose oleate, L1_PEG600: PL90G liposomes containing PEG600-
monooleate, L1_CG: PL90G liposomes containing cetearyl glucoside, L1_PGMO5: PL90G liposomes 
containing PG5-monooleate, L1_PEG1000: PL90G liposomes containing PEG1000-monooleate, L1_TE: 
PL90G liposomes containing polyglyceryl-3 methylglucose distearate, L1_PGMO10: PL90G liposomes 
containing PG10-monooleate, L1_PEG2000: PL90G liposomes containing PEG2000-monooleate, L1_EM: 
PL90G liposomes containing brassicyl isoleucinate esylate, and L1_PS: PL90G liposomes containing DSPS, 
L1_CH: PL90G liposomes containing cholesterol) 
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Hence, emulsifying agents are key components which improve native 
liposome attributes for skin penetration. Fundamentally, there are two important 
characteristics of preferable liposomes for penetration enhancement, 1). liposomal 
membrane should be flexible, allowing it to squeeze easily through skin and 2). 
consideration of emulsifier characteristic incorporating into vesicle membrane for 
producing elastic vesicle should be constructed with small hydrophilic headgroup 
and medium chain unsaturated fatty acid. These liposomes show potential promise 
in dermal drug delivery and commercial cosmetic applications. Future work in this 
area should be focused at two aspects namely increased characterization of studied 
liposomes in relation to drugs that require dermal delivery routes and examine 
combinations of emulsifiers to synergistically enhance liposome performance. 
Zusammenfassung 
Liposomen sind ein wichtiger Bestandteil moderner Strategien der 
Wirkstoffapplikation. Zuletzt entwickelte sich ein gesteigertes Interesse an der 
Anwendung als topisches Trägersystem. In der Vergangenheit waren 
konventionelle Liposomen, deren Bilayer aus Phospholipiden (Soja-
Phosphatidylcholin, und Dipalmitoylphosphatidylcholin (DPPC)) und Cholesterol 
bestehen, nicht in der Lage, effizient durch die Haut zu penetrieren und verblieben 
in den oberen Schichten des Stratum corneums. Eine neue Generation von 
verformbaren Liposomen – Transfersomen®, Ethosomen und Invasomen – wurde 
von Cevc (1996), Touitou et al. (2000) bzw. Dragicevic-Curic et al. (2008) 
entwickelt [1-3], besitzt eine hohe Effizienz, in die Haut einzudringen, eine bessere 
Steuerung der Wirkstofffreisetzung sowie eine Erhöhung der Löslichkeit und 
Stabilität des Wirkstoffes und bietet auf diesem Weg eine Möglichkeit, diese 
biologische Barriere zu überwinden. Der Lipidbilayer dieser Vesikel bestand aus 
ungesättigten Phospholipiden und Penetrationsbeschleunigern – z.B. 
Natriumcholat, nichtionische Tenside (Tween 80®, Span80®, etc.), Terpene, 
welche die Membranstruktur destabilisieren und die Elastizität des Bilayers 
erzeugt. Bisher war und ist noch nicht vollständig bekannt, welche Eigenschaften – 
z.B. Partikelgröße, Oberflächenladung, Flexibilität des Lipidbilayers – näher 
untersucht werden sollten, um die Wirkstoffpenetration zu verbessern, und welche 
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Eigenschaften ein ideales Tensid (welches im Rahmen dieser Arbeit als untersuchte 
Gruppe der Penetrationsbeschleuniger diente) hierfür besitzen sollte. In Anbetracht 
der zur erwähnten Eigenschaften erwarteten wir, dass die Oberflächenmodifikation 
der Liposomen durch verschiedene Tenside unterschiedliche 
Penetrationsfähigkeiten bedingt und uns dadurch eine Richtlinie zur Verfügung 
steht, welche Substanzen in einen Bilayer eingearbeitet werden sollten, um die 
Penetration zu verbessern.  
Um den Einfluss der Emulgatoren zu untersuchen, verwendeten wir daher 
nicht-modifizierte, ungeladene Liposomen mit einem ζ-Potential von -7 mV als 
Ausgangsmodell. Gillet et al. (2011) beobachteten, dass eine negative 
Oberflächenladung die Penetration begünstigt [4]. An anderer Stelle beschrieben 
Manosroi et al. (2004) den gleichen Effekt für positiv geladene Liposomen [5]. 
Dabei handelt es sich um die Nettoladung des Bilayers, die durch die 
Zusammensetzung der Membran (Phospholipide sowie andere Bestandteile, z.B. 
Tenside). Ein anderer Parameter, der die Penetration verbessern kann, ist die 
Membranelastizität. Wir bestimmten den Deformierbarkeitsindex (D) für die 
hergestellten Liposomen und vermuteten, dass hohe Werte für D aufgrund 
steigender Flexibilität mit verbesserter Penetration interpretiert werden können. 
Basierend auf diesen Merkmalen sollte eine liposomale Membran zur weiteren 
Modifikation folgende Eigenschaften aufweisen: geringe oder neutrale 
Oberflächenladung, einen hohen Deformierbarkeitsindex und eine geringe Größe. 
Wir untersuchten fünf Liposomenformulierungen, die aus kommerziellen 
Phospholipiden (PL90G, NAT8539, LPC20, SUN70P und SUN90P) aufgebaut 
waren und wählten PL90G (> 95% ungesättigtes PC) als Kandidat zur weiteren 
Oberflächenmodifikation aus, da es die geringer ausgeprägte negative 
Oberflächenladung besaß als NAT8539 und LPC20 und höhere D-Werte aufwies 
als SUN70P und SUN90P. 
Geladene Phospholipide wie Distearoylphosphatidylglycerol (DSPG) und 
Distearoylphosphatidylserin (DSPS) bildeten Liposomen mit einer negativen 
Oberflächenladung, während der Einbau quartärer Amine (QA) und Brassicyl-
Isoleucinat-Esylat (EM) eine positive Ladung zur Folge hatte. Leicht negativ 
geladene PL90G-Liposomen wurden als Kontrolle verwendet, um diese 
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Modifikationen zu charakterisieren. Die biologische Funktion dieser Liposomen 
wurde an verschiedenen ex vivo hautbasierten Untersuchungen getestet. Tape 
Stripping auf menschlicher Haut und die Bestimmung der penetrierenden 
Liposomen (Franz-Zell-Experimente) unter dieser Haut zeigte eine Penetration 
positiv und negativ geladener Liposomen. Positiv geladene QA-Liposomen zeigten 
dabei eine bessere Penetration als EM-haltige Liposomen und ähnliche Werte wie 
PL90G-beladene Liposomen. In Übereinstimmung mit den Ergebnissen von Gillet 
et al. (2011) [1], konnten wir ebenfalls beobachten, dass negativ geladene DSPG-
Liposomen eine bessere Penetration aufwiesen als DSPS- und PL90G-Vesikel. Die 
Penetrationsverbesserung geht dabei ausschließlich auf den Einbau des an der 
Kopfgruppe ngeativ geladenen DSPGs zurück. 
Da beobachtet werden konnte, dass Modifikationen der Kopfgruppe einen 
Einfluss auf das Penetrationsverhalten ausüben, vermuteten wir im Folgenden, dass 
die Größe der modifizierten hydrophilen Kopfgruppe dieses Verhalten ebenfalls 
verändern kann. Polymere Tenside wie Polyethylenglykol (PEG)-Monooleat und 
Polyglycerol (PG)–Monooleat mit unterschiedlichen Kettenlängen wurden 
verwendet, um Liposomen herzustellen. Verglichen mit den Kontrollliposomen 
erhöhten diese Polymere die Größe der Kopfgruppe und der Vesikel. In 
Übereinstimmung mit vorherigen Untersuchungen konnten wir ebenfalls 
feststellen, dass diese Modifikationen die Lagerstabilität der Formulierungen bei 
Raumtemperatur verbesserte. Eine Verlängerung der Polymerketten resultierte in 
einer Zunahme der Größe, was allerdings keinen Einfluss auf das 
Penetrationsverhalten hatte. Es sollte erwähnt sein, dass der Einbau von 
Emulgatoren mit kleinen Kopfgruppen, gleichzeitig die Membranelastizität und 
Hautpenetration verbessern kann, wohingegen eine große Kopfgruppe keine 
Verbesserung der Hautpenetration zeigte. Die geringste Polymergröße in PEG-
Monooleat (PEG300) und PG-Monooleat (PGMO4) konnten den D-Wert und die 
prozentuale Verkapselungseffizienz der modifizierten Liposomen im Vergleich zur 
Kontrolle erhöhen. Sie zeigten zusätzlich im Vergleich zu den höher 
polymerisierten Analogas ein verbessertes Penetrationsverhalten. Die Größe 
(Molmasse) der hydrophilen Kopfgruppe und der Emulgator haben einen 
signifikanten Einfluss auf das Verhalten der Formulierung; in unserem Fall konnten 
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wir feststellen, dass Liposomen, deren Oberfläche mit dem PEG300-Polymer 
(MW~300) modifiziert waren, eine deutlich bessere Hautpenetration besaßen als 
Vesikel, die mit dem PGMO4-Polymer (MW~500) modifiziert wurden. Ein Grund 
hierfür können verstärkte sterische Effekte sein, die einen direkten Einfluss auf die 
Kopfgruppen der Phospholipide ausüben können und dadurch die Eigenschaften 
der Liposomen verbessern können. Wir beobachteten ebenfalls, dass der Einbau 
einer polymeren Kopfgruppe und die daraus folgende Vergrößerung der Vesikel 
eng mit dem Penetrationsverhalten in ex vivo-Studien zusammenhängen. 
Modifikationen der Kopfgruppen können des Weiteren zu tiefgreifenden 
Veränderungen in der Ordnungsstruktur des liposomalen Bilayers führen. Es ist 
bekannt, dass Liposomen durch eine entsprechende Flexibilität der 
Vesikelmembran einfacher in das Stratum corneum penetrieren. Ungeladene 
Tenside - wie z.B. Zuckerderivate - verändern die Packung des Bilayers und 
resultieren damit in einer Änderung des Deformabilitätsindexes, welche zu einer 
erhöhten Flexibilität beiträgt [6]. In der vorliegenden Arbeit wurden drei 
verschiedene Zuckerderivate zur Modifikation der Membranordnung verwendet, 
nämlich Saccharoseoleat, Cetearylglucosid und Polyglycerol- 3- 
Methylglucosedistearat. Alle drei Substanzen konnten in der Vergangenheit ihr 
Potential zur Verbesserung der Hautpenetration darlegen. Saccharoseoleat und 
Cetearylglucosid wiesen dabei sehr ähnliche Penetrationskinetiken in die Haut auf. 
Verglichen dazu, wurde für das komplexere Molekül Polyglycerol-3-
Methylglucosedistearat eine geringere Hautpenetration beobachtet. Diese Resultate 
lassen vermuten, dass eine strukturelle Komplexität der Kopfgruppe die Erhöhung 
des Penetrationseffektes beschränkt. Trotz struktureller Ähnlichkeiten zwischen 
Saccharoseoleat und Cetearylglucosid (beide besitzen eine kleine hydrophile 
Kopfgruppe und einen hydrophoben Rest) erzielte erstgenanntes die höchste 
Penetrationseffizienz. Dieser Fakt lässt sich womöglich auf Unterschiede in der 
Konformation zurückführen; Saccharoseoleat besitzt eine ungesättigte C18:1 
Fettsäurekette, wohingegen letztgenannte eine gesättigte C18:0 Fettsäurekette 
besitzt, wodurch der Lipidbilayer im Fall von Saccharoseoleat lockerer gepackt und 
dadurch flexibler ist. 
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Die Modifikation von Liposomen durch Veränderungen der 
Kopfgruppenschicht ist ein geeignetes Werkzeug, um die Eigenschaften der 
Vesikel zu verbessern. Nichtsdestotrotz stellt die Modifizierung des 
Hautbarrierenwiderstandes einen noch potenteren Ansatz dar, um das Stratum 
corneum empfänglicher für Liposomen zu machen. Erreicht wird dies durch 
Agentien, welche entweder die molekulare Ordnung der Hautlipide stören und 
damit Penetrationskanäle schaffen oder bereits vorhandene Poren im Stratum 
corneum nutzen um den Wirkstoffeintritt und -transport zu gewährleisten. Obwohl 
bereits einige dieser Substanzen zur Veränderung der Hautcharakteristiken 
beschrieben sind, wurden in der vorliegenden Arbeit drei weitere Vertreter 
untersucht. Dabei handelte es sich um stark lipophile Komponenten wie eine 
Terpenmischung, ein ungeladenes Tensid wie Tween 80 und Phospholipide, welche 
schlussendlich die Barrierefunktion der Haut beeinflussen und die Penetration 
verbessern sollten. Der Oberbegriff solcher Agentien lautet 
Penetrationsbeschleuniger [7, 8]. Verschiedene Liposomentypen wurden 
hergestellt, darunter Transfersomen (unter Nutzung von Tween 80) [9], Invasomen 
(unter Nutzung der Terpenmischung) [3] und Liposomen bestehend aus 
Phospholipiden. Diese wurden anschließend mit konventionellen Liposomen 
verglichen, welche durch Dispersion neutraler Lipide mit Cholesterol hergestellt 
wurden. Die Verbesserung von Penetrationseigenschaften ist ein komplexer 
Vorgang, der oftmals von vielen Aspekten der Liposomen abhängig ist. Es wurde 
beobachtet, dass Invasomen die Haut besser penetrieren als Transfersomen, wobei 
konventionelle Liposomen nicht in der Lage waren die Haut effektiv zu penetrieren. 
Daraus lässt sich schlussfolgern, dass Liposomen auf Terpenbasis bessere 
Membranelastizitäten und penetrationsverbessernde Eigenschaften besitzen. 
Schlussfolgerungen 
Neutrale Liposomen wie PL90G stellen ein ideales Modell dar, um die Effekte von 
Oberflächenmodifikationen hinsichtlich ihres Potentials zur Verbesserung des 
Liposomenverhaltens zu bewerten. In der vorliegenden Arbeit wurde ebenfalls 
festgestellt, dass die Oberflächenladung von Liposomen durch den Einbau von 
Emulgatoren (besonders das negativ geladene DSPG) dazu befähigt ist, die 
biologische Leistungsfähigkeit von Liposomen, verglichen mit unmodifizierten 
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Vesikeln, zu verbessern. Liposomen mit den polymeren Kopfgruppen PEG300 und 
PGMO4 können effizient ins Stratum corneum penetrieren, wobei die 
Verbesserung durch eine gewisse Größe begrenzt wird und sich nicht auf den 
gesamten Größenbereich übertragen lässt. Liposomen mit inkorporiertem 
Saccharoseoleat eignen sich besser als andere Zuckerderivate, da sie in 
synergistischer Art und Weise die liposomalen Bilayer-Charakteristiken (z.B. 
Membranoberfläche) modifizieren und das Stratum corneum für eine 
Penetrationsverbesserung verändern. Ebenso werden die Hautbarrierefunktionen 
durch Penetrationsagentien beeinflusst, womit ein Zusatznutzen gegenüber 
konventionellen Liposomen erkennbar ist. Im Zuge dieser Beobachtungen und 
Diskussion ist es möglich einen Vier-Stufen-Index auf Grundlage eines CF-
Permeations-Assays (Abbildung 22) zu entwickeln.  
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Abbildung 22 Vergleich der kumulativ permeierten Mengen an CF verschiedener PL90G-basierten 
Liposomen durch die Haut. (L1_PG: PL90G Liposomen mit DSPG, L1_PEG300: PL90G Liposomen mit 
PEG300-Monooleat, L1_TP: PL90G Liposomen mit Terpenmischungen, L1_PGMO4: PL90G Liposomen mit 
PG4-Monooleat, L1: PL90G Liposomen ohne Zusätze, L1_TW: PL90G Liposomen mit Tween80, L1_QA: 
PL90G Liposomen mit QA, L1_SO: PL90G Liposomen mit Saccharoseoleat, L1_PEG600: PL90G Liposomen 
mit PEG600-Monooleat, L1_CG: PL90G Liposomen mit Cetearylglucosid, L1_PGMO5: PL90G Liposomen 
mit PG5-Monooleat, L1_PEG1000: PL90G Liposomen mit PEG1000-Monooleat, L1_TE: PL90G Liposomen 
mit Polyglyceryl-3 Methylglucosedistearat, L1_PGMO10: PL90G Liposomen mit PG10-Monooleat, 
L1_PEG2000: PL90G Liposomen mit PEG2000-Monooleat, L1_EM: PL90G Liposomen mit 
Brassicylisoleucinatesylate, und L1_PS: PL90G Liposomen mit DSPS, L1_CH: PL90G Liposomen mit 
Cholesterol) 
Folglich stellen Emulgatoren die Schlüsselkomponente zur Verbesserung von 
Liposomenattributen hinsichtlich der Hautpenetration dar. Grundsätzlich sind 
geeignete Liposomen zur Penetrationsverbesserung durch zwei wichtige Faktoren 
gekennzeichnet, 1.) die liposomale Membran sollte flexibel sein und somit einen 
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einfachen Durchgang durch die Haut gewährleisten und 2.) die Emulgatoren zum 
Einbau in die Vesikelmembran sollten aus kleinen hydrophilen Kopfgruppen und 
mittellangen ungesättigten Fettsäuren bestehen, um elastische Vesikel herstellen zu 
können. Solche Liposomen besitzen ein vielversprechendes Potential im Bereich 
des dermalen Arzneistofftransports und der kommerziellen Kosmetik. 
Weiterführende Arbeiten sollten sich verstärkt auf die Charakterisierung von 
liposomalen Formulierungen richten, deren Wirkstoff eine dermale 
Applikationsroute benötigt und des Weiteren die Kombination von Emulgatoren 
zur synergistischen Verbesserung der Liposomenpenetration untersuchen. 
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Appendix A: Data with standard deviation 
I. Phospholipids selection for preparing model liposomes 
Table 1 The composition and characterization of non-entrapped phospholipid 
liposomes by vesicle size, PDI, zeta potential and deformability. 
Code Composition 
Vesicle size 
(nm)a 
PDIa 
Zeta potential 
(mV) a 
Deformability index 
(D) a 
L1 PL90G:EtOH=10:16 65.37 ± 2.13 0.28 ± 0.01 -5.75 ± 0.87 2.014 ± 0.21 
L2 NAT8539:EtOH=10:16 69.48 ± 1.77 0.03 ± 0.05 -40.16 ± 0.74 1.260 ± 0.21 
L3 LPC20:EtOH=10:16 174.93 ± 2.41 0.22 ± 0.12 -56.12 ± 1.24 2.894 ± 1.09 
L4 SUN70P:EtOH=10:16 33.33 ± 0.36 0.22 ± 0.00 -2.55 ± 0.81 0.354 ± 2.88 
L5 SUN90P:EtOH=10:16 95.29 ± 0.66 0.37 ± 0.01 -1.50 ± 0.32 1.707 ± 3.41 
a Average of three determinations ± standard deviation (S.D.) 
Table 2 Physicochemical properties of phospholipid liposomes entrapped with 
carboxyfluorescein (CF) 
Code Vesicle size (nm)a 
%Entrapment 
efficiency (%EE) a 
CF-L1 44.60 ± 2.25 35.10 ± 3.89 
CF-L2 70.21 ± 1.77 28.18 ± 1.77 
CF-L3 175.77 ± 2.41 30.77 ± 7.41 
CF-L4 43.58 ± 0.56 25.48 ± 7.88 
CF-L5 82.21 ± 0.74 27.12 ± 6.21 
a Average of three determinations ± standard deviation (S.D.) 
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II. Influence of surface charge on drug penetration performance of 
liposomes 
Table 1 Prepared liposomal formulations of charged liposomes 
Formulation Code PL90G DSPG DSPS EM QA 
L1_PGa 9 1 - - - 
L1_PSb 9 - 1 - - 
L1_EMc 9 - - 1 - 
L1_QAd 9 - - - 1 
Add 16%w/w Ethanol and 74%w/w 30mM CF solution/ PBS in each formulation. 
a L1_PG: PL90G liposomes containing distearoyl phosphatidylglycerol (DSPG) 
b L1_PS: PL90G liposomes containing distearoyl phosphatidylserine (DSPS) 
c L1_EM: PL90G liposomes containing brassicyl isoleucinate esylate (EM) 
d L1_QA: PL90G liposomes containing quaternary ammonium (QA) 
Table 2 Physical characterization of the different types of charged liposomes 
(2a) 
Formulation 
code 
Particle size (nm)a PDI a 
Zeta potential (mV) 
a 
L1 44.63 ± 2.25 0.19 ± 0.01 -7.45 ± 3.22 
L1_PG 160.9 ± 1.22 0.15 ± 0.02 -55.28 ± 1.24 
L1_PS 167.1 ± 0.88 0.05 ± 0.01 -44.12 ± 4.47 
L1_EM 112.2 ± 1.43 0.30 ± 0.07 54.17 ± 2.11 
L1_QA 30.21 ± 1.67 0.22 ± 0.03 46.57 ± 1.14 
a Average of three determinations ± standard deviation (S.D.) 
(2b) 
Formulation 
code 
Deformability index 
(D) a 
%Entrapment 
efficiency (%EE) a 
L1 2.014 ± 0.21 35.10 ± 3.89 
L1_PG 2.322 ± 0.10 39.22 ± 8.01 
L1_PS 2.901 ± 0.44 49.29 ± 7.02 
L1_EM 11.09 ± 0.05 28.85 ± 3.19 
L1_QA 1.674 ± 0.14 27.09 ± 7.09 
a Average of three determinations ± standard deviation (S.D.) 
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III. Surface modification using polymer coating of liposomes 
Table 1 Characterization of different liposomes 
Formulation Code 
Particle size 
(nm) 
PDI 
Zeta 
potential 
(mV) 
Deformability 
 index (D) 
% Entrapment 
efficiency(%EE) 
CF-PL90Ga 44.60 ± 2.25 0.30 ± 0.01 -7.45 ± 3.22 2.01 ± 0.21 35.10 ± 3.89 
CF-PL90G:PEG300b 89.24 ± 1.21 0.14 ± 0.01 -12.63 ± 1.54 3.67 ± 0.03 37.30 ± 2.35 
CF-PL90G:PEG600c 60.14 ± 0.51 0.09 ± 0.00 -11.77 ± 3.01 2.03 ± 0.20 41.09 ± 2.18 
CF-PL90G:PEG1000d 64.23 ± 0.36 0.20 ± 0.05 -12.58 ± 2.14 1.07 ± 0.12 39.55 ± 3.49 
CF-PL90G:PEG2000e 95.31 ± 0.84 0.15 ± 0.11 -9.58 ± 1.26 0.93 ± 0.20 37.67 ± 4.72 
Values represent mean ± S.D. (n = 3) 
a Conventional liposomes containing CF 
b PL90:PEG300 liposomes containing CF 
c PL90:PEG600 liposomes containing CF 
d PL90:PEG1000 liposomes containing CF 
e PL90:PEG2000 liposomes containing CF 
Table 2 Characterization of different liposomes 
Formulation Code 
Particle size 
(nm)e 
PDI e 
Zeta potential 
(mV) e 
Deformability 
 index (D) e 
%Entrapment 
efficiency(%EE) e 
CF-PL90a 44.60 ± 2.25 0.30 ± 0.01 -7.45 ± 3.22 2.01 ± 0.21 35.10 ± 3.89 
CF-PL90:PGMO4b 50.32 ± 0.20 0.25 ± 0.10 -14.10 ± 3.64 2.40 ± 0.57 32.48 ± 4.22 
CF-PL90:PGMO5c 35.07 ± 0.27 0.18 ± 0.01 -7.99 ± 2.83 1.85 ± 1.02 38.44 ± 1.19 
CF-PL90:PGMO10d 29.12 ± 0.05 0.13 ± 0.01 -4.81 ± 0.37 1.70 ± 0.65 40.21 ± 5.22 
Values represent mean ± S.D. (n = 3) 
a Conventional liposomes containing CF 
b PL90:PGMO4 liposomes containing CF 
c PL90:PGMO5 liposomes containing CF 
d PL90:PGMO10 liposomes containing CF 
e Average of three determinations ± standard deviation (SD). 
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IV. Sugar-derivatives emulsifier effect into lipid bilayer of liposomes 
for membrane fluidization improvement 
Table 1 Physical characterization of the different types of liposomes using 
sugar derivatives. 
Formulation 
Code 
Particle size 
(nm)d PDI
 d 
Zeta potential 
(mV) d 
Deformability 
index (D) d 
%Entrapment 
efficiency (%EE) d 
L1 44.6 ± 2.25 0.19 ± 0.01 -7.45 ± 3.22 2.014 ± 0.21 35.10 ± 3.89 
L1_SO a 67.76 ± 7.48 0.17 ± 0.03 +5.87 ± 1.74 3.297 ± 0.05 58.44 ± 6.18 
L1_CG b 119.3 ± 3.63 0.25 ± 0.01 -13.57 ± 2.52 3.192 ± 0.02 54.26 ± 3.40 
L1_TE c 72.98 ± 3.14 0.29 ± 0.02 -35.47 ± 1.77 3.253 ± 0.13 49.95 ± 3.04 
Add 16% Ethanol and 74% 30mM CF solution in each formulation. 
a L1_SO: PL90 liposomes containing sucrose oleate 
b L1_CG: PL90 liposomes containing cetearyl glucoside 
c L1_TE: PL90 liposomes containing polyglyceryl-3 methylglucose distearate 
d Average of three determinations ± standard deviation (S.D.) 
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Appendix B: Statistical analysis  
I. Phospholipids selection for preparing model liposomes 
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***, P < 0.05; **, P < 0.01; n.s., non-significant
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II. Influence of surface charge on drug penetration performance of 
liposomes 
 
 
***, P < 0.05; **, P < 0.01; n.s., non-significant
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III. Surface modification using polymer coating of liposomes 
1. PEG mono-oleate 
***, P < 0.05; **, P < 0.01; n.s., non-significant 
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2. PG mono-oleate 
***, P < 0.05; **, P < 0.01; n.s., non-significant 
94 
 
IV. Sugar-derivatives emulsifier effect into lipid bilayer of liposomes 
for membrane fluidization improvement 
***, P < 0.05; **, P < 0.01; n.s., non-significant 
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